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 The stress response and stressful stimuli are a significant risk factor for a variety of 
chronic disease conditions. Stress mediates its effects on chronic disease in part through 
activation of the IL-1 arm of the immune system, which plays a critical role in behavioral 
modification during stress. Of the various stress theories, only the allostatic model of stress can 
completely account for how stress can induce a positive adaptation to a stressor or lead to 
chronic disease. In this theory, energy state is the primary signal for whether or not a stressor is 
going to induce beneficial or detrimental adaptation. Here, we show that energy state regulates 
the IL-1 arm of the neuroimmune system to affect behavioral change in response to allostatic 
overload. In the first study, mice were provided ad lib access to food or fasted for 24 h to induce 
low energy levels. 24 h fasting in mice reduces the activity of caspase-1 in whole brain and in the 
prefrontal cortex, amygdala, hippocampus, and hypothalamus by 35%, 25%, 40%, 40%, and 
40% respectively. A 24 h fast also results in a 40% reduction in anxiety-like behavior and a 21% 
and 31% increase in novel object and object location recognition, respectively, at 24 hours 
following fasting. ICV administration of the caspase-1 inhibitor biotin-YVAD-cmk reduces 
caspase-1 activity in the prefrontal cortex and amygdala by 55%, respectively, and results in a 
64% reduction in anxiety like behavior. Importantly, when caspase-1 or IL1-R1 knockout (KO) 
mice are fasted, no fasting-dependent reduction in anxiety-like behavior is observed. These 
results suggest that low energy levels inhibit inflammasome activation and improve behavioral 




Next, we sought to determine if high-energy states induce detrimental effects to cognition 
in opposition to the effects of low-energy status. We show that acute refeeding for 2 hr with 
high-fat diet (HFD), but not chow or low-fat diet (LFD) reduces novel object recognition (NOR) 
and novel location recognition (NLR) memory by 13% and 14% respectively.  Additionally, 
HFD refeeding increases caspase-1 activity in the amygdala by ~100%. Novel object and Novel 
location recognition performance was negatively correlated with kcal consumption during 
refeeding, while caspase-1 activity was positively correlated with kcal consumption. Further, 
genetic deletion of either caspase-1 or IL1R1 eliminated recognition memory impairments due to 
HFD refeeding. Oxidative stress played a causal role in caspase-1 activation and cognitive 
dysfunction, as the antioxidant n-acetylcysteine (NAC; 50 mg/kg) improved NOR and NLR 
performance by 18% and 14% respectively, and reduced caspase-1 in HFD fed animals by 169%. 
Finally, a free-fatty acid receptor 1 (FFAR1) antagonist, capable of inhibiting palmitic acid 
induced GPCR activity, improved NOR and NLR by 12% and 14% over vehicle treated HFD fed 
mice. However, FFAR1 antagonism did not have any effect on caspase-1 activation. Taken 
together, these data show that acute overconsumption during refeeding causes caspase-1 
activation in the amygdala which plays a causal role in the cognitive response to type 2 allostatic 
overload, and this response is mediated by a mechanism involving oxidative stress developed 
from excess calorie consumption. 
 
 Finally, we wanted to determine if local energy state played a role in the behavioral 
response to a psychological stressor. We show that 6 hr of chronic experimental stressors can 
impair memory by 12% in the NOR task and increase activation of caspase-1 by 86% within the 
amygdala. Memory deficits following stress exposure are dependent on caspsase-1 activation and 
iv 
 
IL-1β signaling pathways. Interestingly, β-adrenergic antagonist propranolol but not the 
glucocorticoid antagonist mifepristone was able to ameliorate memory deficits and 
neuroinflammation following stress. Further, we demonstrate that extracellular adenosine acts as 
critical danger signal mediating the effects of stress on inflammasome activation and memory 
impairment. Our results demonstrate a novel pathway originating from the catecholamine 
response to stress, that leads to adenosine release and subsequent caspase-1 activation and 
memory impairment. In conclusion, the inflammasome complex operates as a master regulator of 
the stress response in the amygdala by responding to energy state during stress exposure and 
allostatic overload. Through this mechanism we have shown that low-energy states induced by 
fasting produce beneficial behavioral adaptations that lower anxiety-like behaviors and improve 
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CHAPTER 1: LITERATURE REVIEW 
Summary 
 Stress is a near ubiquitous process in which processing of external stimuli result in 
physiological changes in an organism. More recently, stress has been shown to be a significant 
risk factor for chronic diseases such as cardiovascular disease, obesity, diabetes, gastrointestinal 
disease, and neurological diseases. Two fundamental aspects of the stress response are the 
activation of the sympathetic nervous system and hypothalamic-pituitary-adrenal axis to promote 
the secretion of the catecholamines and glucocorticoids respectively. These stress hormones 
induce profound changes in metabolism, immune function, and behavior. However, these effects 
are not always uniform and certain stressors produce paradoxical behavioral effects even when 
acting through the same molecular mediators. The concepts of allostasis, allostatic load, and 
allostatic overload provide the appropriate framework for dealing with these variabilities in the 
stress response, especially behavioral change. In this paradigm, signals of relative change in 
energy level are responsible for regulating the stress response. Further, the inflammasome 
complex represents one possible cellular regulator capable of sensing energy state by a variety of 
molecular mediators, which also interacts with the immune and behavioral systems that stress 
modulates.  Taken together, this evidence suggests that the inflammasome operates within the 
amygdala to regulate the behavioral response to stress by managing allostatic overload.  
 
Introduction 
Beginning with his studies on general adaptation syndrome (GAS), Hungarian 
endocrinologist Hans Selye discovered the fundamental processes that he termed “stress”. He 
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spent the rest of his career further refining the complex interactions between stress, health, and 
disease (Selye, 1951a, Selye, 1951b. Selye, 1955, Selye, 1959). With his discoveries, Selye 
revolutionized the ways in which we think about how organisms interact with their environment, 
and the implications of the environment on the life cycle and health of an organism. In the 
decades since his pioneering work, teams of scientists have probed the inner workings of the 
stress response to discover just how expansive its effects are. Around the time of Selye’s first 
discoveries, cortisone was also isolated from the adrenal cortex (Hartman and Brownell, 1930), a 
discovery Selye used to elicit the mechanism steroids play in GAS (Selye, 1971). Selye 
suggested that the common element of a stressor is to elicit both damage and defense 
mechanisms (Selye, 1952). In cases such as an infection or a wound, this dual response is 
unquestionably beneficial, as it will assist in minimizing the damage from the stressor, as well as 
provide increased defense to any noxious stimuli during recovery. Since these initial discoveries 
our understanding of how these mechanisms of adaptation due to stress has grown to encompass 
nearly every organ system. 
 
More recently, we have discovered how stress can be detrimental to health.  Using 
today’s advances in medicine it has been shown that stress can act as a significant independent 
risk factor, and play an important role in the pathophysiology of many chronic diseases that are 
becoming more prevalent in developed nations (WHO, 2017).  One of the first cases to highlight 
the role of stress in disease was peptic ulcers, where a connection with so-called “stress 
syndrome” had been identified as far back as 1951 (Lillehei et al., 1951, Gray et al., 1951). The 
idea that stress caused ulcers was the dominant theory until the discovery of the involvement of 
H. pylori by Barry Marshall and colleagues. But ulcers do not represent the full extent to which 
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stress affects the gastrointestinal (GI) system. Stress levels are a predictive factor of the presence 
of functional GI disorders in student populations (Suarez et al., 2010). Additionally, stress acts 
through a variety of mechanisms to modulate GI disease. One way stress affects GI function is 
by decreasing barrier function in the in the jejunum and colon in rats (Lauffer et al., 2016). 
Interestingly, GI disease is a well-known model of the unique effects of stress at certain 
developmental states. Early-life stress is a model for several GI diseases (Pohl et al., 2015). 
Finally, treatment options are expanding to help treat stress effects that lie at the heart of the 
dysfunction (Qin et al., 2014). While GI diseases served as early proof of concept cases for the 
involvement of stress in disease, its effects extend to metabolic diseases as well.  
 
As one of the most common metabolic diseases, diabetes is also significantly affected by 
stress levels. Stress has been implicated in both type I and type II diabetes in human and animal 
trials. Epidemiological studies have shown that stress and salivary cortisol are significant factors 
in the development of type II diabetes (Siddiqui et al., 2015). In type I diabetics, higher stress 
levels have been shown to be related to higher levels of the clinical marker HbA1c, which 
measures glucose tolerance (Ortiz and Myers, 2014). Stress also modulates the blood glucose 
response following meals (Faulenbach et al., 2012). Additionally, stress also affects 
cardiovascular disease (CVD). Although conventional biomarkers like lipid levels have been 
used for decades, recent work suggests stress is potentially a better predictor of CVD (Kurd et 
al., 2014). Even strictly psychological stressors affect CVD. These include uncommon life 
events, work and home stress, and SES status which promote detrimental physiologic processes 
(Watanabe, 2008). While these human studies describe the larger effects of stress, animal studies 
remain crucial to understanding the cellular mechanisms of stress. Chronic psychological stress 
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induced by chronic restraint increases platelet aggregation (Matsuhisa et al., 2014) This is an 
important pre-clinical finding, as increased platelet aggregation is a pathological indication of 
cardiovascular disease. Connected to the cardiovascular system, the pulmonary system is also 
susceptible to damaging effects from stress. Due to the connection between stress and the 
immune system, inflammatory diseases like asthma are particularly sensitive to stress effects. As 
an example, the bronchodilator response is decreased in highly stressed children and in children 
with highly stressed parents (Brehm et al., 2015). This study also showed that the effects of 
stress were dependent on a single-nucleotide polymorphism (SNP) in a gene known to be related 
to anxiety, another disease highly regulated by stress. It has been suggested that stress may be 
part of a feed –forward mechanism exacerbating asthma symptoms, where the physical 
manifestations of the condition impose their own psychological stress on the individual (Lind et 
al., 2014). While these data show the wide variety of effects stress has on several important 
organ systems, the central nervous system is perhaps the system most affected by stress. 
 
The discovery of ACTH release from the brain provided evidence of the importance of 
the brain to the stress response (Collip et al., 1943). Due to this importance of the brain to stress, 
neurological diseases are significantly affected by stress. The most obvious example of the 
detrimental effects of stress is PTSD. Stress effects can also be seen during mood disorders. In 
fact, psychological stress is significantly related to poor scores on clinical exams for depression 
and anxiety (Fan et al., 2015). Additionally, stress can change brain structure in depressed 
patients. Patients with depression exhibit increased levels of corticotropin-releasing factor (CRF) 
neurons, responsible for initiating the stress response, in the paraventricular nucleus (PVN) of 
the hypothalamus (Raadsheer et al., 1994). Life-cycle stress also affects the brain. Prenatal stress 
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induces changes in the amygdala in offspring due to CRF exposure, which leads to behavioral 
abnormalities later in life (Cratty et al., 1995). In animal models of Alzheimer’s disease, chronic 
mild stress accelerates the progression of the disease (Cuadrado-Tejedor et al., 2012). However, 
even subclinical memory impairment is affected by stress. The physiologic correlate of learning, 
long-term potentiation (LTP), is reduced following stress in animal models (Grigoryan et al., 
2014). As a life-changing diagnosis, Alzheimer’s causes stress effects even to those around the 
patient. Caregivers for Alzheimer’s patients have been found to have significantly more stress, 
depression, and anxiety. Further, when administered cognitive tests caregivers score worse than 
non-caregivers (Correa et al., 2015). It has also been suggested that stress can shift memory 
systems from “cognitively flexible”, a state of increased ability to learn and remember, to 
“inflexible”, rigid thought processes associated with psychopathologies (Schwabe and Wolf, 
2013). Global cognition, the overall cognitive function of an individual, is also affected by stress. 
In one of the largest studies of how stress affects cognition it was found that those with highest 
levels of stress events over the preceding 10 years also had the lowest global cognitive ability 
(Leng et al., 2013).  
 
Finally, nutritional status is a significant independent factor in the individual variability 
in the stress response. Particularly, fat-soluble vitamins appear to be a crucial component of an 
individual’s response to stress. Vitamin A deficiency has been shown to temporally shift, and 
increase, the glucocorticoid response to stress (Marissal-Arvy et al., 2013). Vitamin A deficiency 
also increases corticosterone levels which have been linked to cognitive and anxiety-like 
behavioral complications. Reintroducing vitamin A to the diet can ameliorate these effects 
(Bonhomme et al., 2014). Further, vitamin E, important for preventing lipid peroxidation, 
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reduces catecholamine responses following stress (Mohd Fahami et al., 2012). Vitamin E has 
also been shown to be effective at mitigating the effects of exogenous glucocorticoids (Williams, 
D et al., 2012, Gao et al., 2010, Ohtsuka, 1998). Even nonessential nutrients play a role in 
modulating the stress response. Capsaicin, the bioactive component of chili peppers, reduces 
cognitive impairment due to stress (Jiang et al., 2013). Curcumin, the active ingredient of 
turmeric, has also been shown to reduce depressive-like behaviors during chronic stress (Zhang 
et al., 2014). In addition to vitamins and non-essential nutrients, even macronutrients such as 
fatty acids regulate the stress response. Particularly, the essential fatty acids, the omega-3s, found 
in fish oil appear most beneficial (Tang et al., 2015). Omega-3s work in human patients as well, 
where supplementation reduces stress levels in high-stress individuals (Hellhammer et al., 2012). 
Finally, overall dietary patterns can significantly affect the stress response. High-fat diet (HFD) 
feeding, a model for obesity, when combined with a chronic stress paradigm exacerbates markers 
of atherosclerosis (Wang et al., 2014). High-fat diets also induce alterations in the response to 
CRF treatment (Legendre et al., 2007). As one of the most prevalent ways we interact with our 
environment, it makes teleological sense that nutrition plays a critical role in the stress response.  
 
The preceding review of the myriad ways in which stress regulates disease processes in 
organ systems proves just how important understanding the mechanisms of stress is, especially 
because stressors can produce both positive and negative effects. However, we still have little 
understanding of the molecular mechanisms of the stress response, especially how variable 
responses can come from physiologically similar stressors. This review will examine the current 
literature on various theories of stress and the mechanisms by which stress exerts its 
physiological effects while paying particular attention to the role of the amygdala in the stress 
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response. Further, we will detail evidence that describes how the immune sensor known as the 
inflammasome complex acts as an energy sensor during allostatic overload to function as the 
molecular switch regulating the stress response. 
 
The allostatic response to stress 
  The homeostatic model of stress has been the dominant theory explaining the 
endogenous stress response to an external stressor since its first appearance in the literature in the 
1930’s (Cannon, 1963). In the homeostatic model, variables affected by stress are autoregulated 
back to static “set points” following the down regulation of the stress response (Koolhaas et al., 
2011). Traditionally, this autoregulation is achieved by a process where the stress response 
begins with the sensing of stress stimuli by the peripheral nervous system. These stress stimuli 
are sensed as perturbations in homeostatically regulated variables such as blood pressure, heart 
rate, blood glucose, and external cues such as the appearance of predator threats (Chrousos and 
Gold, 1992, Ulrich-Lai and Herman, 2009). These trigger reflex arcs that communicate to the 
main homeostatic centers in the hypothalamus and brainstem and regulate the Hypothalmaus-
pitutary-adrenal (HPA) axis and the autonomic nervous system (ANS), respectively. This ANS 
response includes activation of the sympathetic nervous system (SNS) and inhibition of the 
parasympathetic nervous system (PNS), thus triggering the classic “fight-or-flight” response 
(McCorry, 2007). The main objective of this response is to increase energy mobilization, activate 
systemic defenses to danger, and prepare the body for action. Further, the sympathetic nervous 
system is responsible for the catecholamine response to stress, and initiates the release of 
epinephrine and norepinephrine from the adrenal medulla (Won and Kim, 2016). The 
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catecholamines then signal back to the brain to reinforce the stress response (Smith and Vale, 
2006). Principally, as the brain region with the largest proportion of noradrenergic neurons, the 
Locus coeruleus (LC) integrates these signals and projects into the hypothalamus to propagate 
the HPA portion of the stress response. It also projects into other areas, such as the amygdala 
(Pickel et al., 1974).  
 
When signaling to the hypothalamus stress stimuli project to the paraventricular nucleus 
(PVN) of the hypothalamus to activate the HPA axis (Ulrich-Lai and Herman, 2009). Upon 
activation, neurons within the PVN secrete corticotropin-releasing factor (CRF) (Smith and Vale, 
2006). CRF then signals to the pituitary through two distinct receptors (Perrin and Vale, 1999), 
with the CRFR1 variant serving as the mediator of the neuroendocrine response to stress. 
Activation of CRFR1 in the pituitary triggers the release of adrenocorticotropic hormone 
(ACTH) into systemic circulation. Once in circulation ACTH travels to the adrenal cortex where 
it binds the melanocortin type 2 receptor (MC2-R) (Smith and Vale, 2006), triggering the release 
of glucocorticoids (GCs), the other main stress hormone. The GCs then act as a negative 
regulator of the stress response by inhibiting ACTH production. This decreases HPA axis 
activation and SNS activity to terminate the stress response. The GCs, upon binding to the 
glucocorticoid receptor (GR) and translocating to the nucleus, inhibit transcription of ACTH 
within the pituitary to inhibit the indefinite propagation of the stress response (Keller-Wood and 
Dallman, 1984). However, such a complex system can easily be perturbed by a variety of genetic 
(DeRijk et al., 2008), nutritional (Dauncey et al., 2001), and other factors (Enserink, 2015) that 
will modify how an individual responds to a specific stressor. Additionally, free-living organisms 
have anticipatory, seasonal, and deleterious variations in such systems (Schulkin, 2003). A very 
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obvious example is changes in fat pad mass during preparation for winter in a variety of animals. 
In the homeostatic model, such increases in fat mass would trigger the stress response and fat 
mass would return to “normal” levels. Two other examples are blood pressure and obesity, which 
increase with age. As our understanding of the dynamics of the stress response has evolved over 
the decades since the inauguration of the homeostatic model, ever more scenarios that are 
incompletely explained like these have become apparent. Given the role of stress in several 
chronic disease states a critical question is how can the stress response, which should, under the 
homeostatic model, quickly return function to normal levels, become so unbalanced in these 
disease states? 
 
 Developed in 1988, the concept of allostasis, defined as stability through change, helps to 
account for the fact that many systems are not regulated back to specific set-points following 
stressors (Sterling and Eyer, 1988). Additionally, allostasis fully accounts for the variety of 
neural, immune, endocrine, metabolic, and behavioral inputs into stress response, whereas 
homeostasis presumes each system is regulated in isolation. While allostasis helps to account for 
variable changes with internal function, dynamic modulation of various systems to maintain a 
steady state is a costly venture for an organism to undertake, despite the advantages it poses for 
responding to external stressors (McEwen and Stellar, 1993). The cost of this dynamic regulation 
has been termed “allostatic load” (McEwen and Stellar, 1993). Further development of the 
allostasis concept has identified three main responses to stressors that contribute to allostatic 
load. The first is frequent stressors, which the homeostatic model frequently fails to properly 
explain (McEwen, 1998). In the homeostatic model, repeated stressors would each be treated 
individually, and corrected by the same response. This allows for no adaptation to the stressor, 
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and eliminates any ability to more efficiently manage similar stressors in the future.  The second 
is a failed shut down response to a stressor (McEwen, 1998). In this scenario, aspects of the 
stress response remain chronically elevated, and never return to a steady state. This can cause 
improper elevations in a variety of cellular mediators, and lead to disease. Two possible 
examples would be an increase in a counter-regulatory response to reduce the chronically 
elevated response element, or an increase in several other systems to reach equilibrium at a 
newly elevated set point. The third and final type of allostatic load is an inadequate response 
(McEwen, 1998). In this scenario a stressor does not stimulate the appropriate response of one 
system, and another, potentially more disastrous, system fills in for the appropriate system and 
induces dysfunction.  Or, all other complementary systems may also fail to activate to the higher 
levels necessary to combat the stress, and inhibit the formation of an adaptive response to the 
stressor. 
 
 When these responses are extended beyond the time frame of the stressor, or other 
demands or stimuli are introduced, allostatic load can no longer be maintained, and allostatic 
overload begins (McEwen and Wingfield, 2003). The overload response is determined by the 
ability of the organism to deal with the cascade of demands imposed on it. To do so, it resorts to 
monitoring energy level to determine the appropriate response. In the type 1 overload response, 
the organism has insufficient energy resources, including the ability to gather new energy and the 
internal mobilization of energy stores, to meet the demand of the allostatic load imposed, and 
further adaptations are initiated (McEwen and Wingfield, 2003). In this manner, the type 1 
allostatic overload response induces responses to deal with reduced energy levels during stress, 
which produce beneficial adaptations that allow for resistance and avoidance of future stressors. 
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In the type 2 allostatic response, energy resources exceed the demand imposed by allostatic load, 
and further adaptations are initiated (McEwen and Wingfield, 2003). In this response to allostatic 
overload, high energy levels signal that any stressor experienced is not likely to pose a very 
detrimental effect to the organism, and negative effects begin to occur due to activation of the 
stress response to an unnecessary stressor. In ad lib fed animal models of stress the type 2 
response is the prevailing response. This is because the stress hormones mobilize stored energy, 
even though the animal is already at an adequate energy state, and has no capacity to further 
utilize mobilized stores. These mobilized energy substrates can then further induce dysfunction 
throughout the body.  
 
It is well known that there is an overriding need of an organism to manage its energy 
level, like its reproductive function, that regulates behavior and physiology. During allostatic 
overload, this overriding response to energy level, and not a variation in the more common 
neuroendocrine mediators of stress, that most properly describe why certain stressors induce 
robust coping adaptations that provide current and future benefits to the organism, and why 
others produce negative effects associated with the pathology of disease. It is precisely this 
regulation of allostatic overload by energy levels that allows it to account for the wide variety of 
stress effects that the homeostatic model cannot account for. However, even the allostatic model 
incorporates mechanisms involving the classical mediators of the stress response, the GCs and 
catecholamines. To begin, we will examine some of these mechanism by which the stress 




Mechanisms of allostatic load 
In both the homeostatic and allostatic models of stress, the GCs play critical roles in the 
response to stimuli that disrupt equilibrium in bodily systems. The GCs are able to exert this 
influence by acting as a transcription factor and regulate a variety of cellular processes through 
this mechanism (Kumar and Thompson, 2005). Metabolically, the glucocorticoids induce many 
changes in glucose and lipid metabolism. First, they regulate glucose homeostasis in a variety of 
tissues (Kuo et al., 2015). In the liver, GCs increase gluconeogenesis and glycogen storage by 
increasing the transcription of the gluconeogenic pathway genes such as PC, PCK1, FBP1, 
PFKFB1, and G6PC (Kuo et al., 2015). For glycogen storage, GCs increase the activity of 
glycogen synthase. While these changes increase energy mobilization, GCs can act negatively on 
metabolic function too. In skeletal muscle GCs inhibit glucose utilization, glycogen storage, and 
increases protein catabolism. These effects are likely due to the ability of the GCs to induce 
insulin resistance (Morgan et al., 2009). During the development of insulin resistance GCs 
reduce insulin receptor substrate-1 (IRS-1) expression, and inactivate it through serine 
phosphorylation (Morgan et al., 2009). GCs have several additional cellular effects.  Oxidative 
stress, a cellular stressor, can be increased by GC inhibition of the cellular antioxidant super 
oxide dismutase (Sato et al., 2010). These changes demonstrate how allostatic load can, over 
time, progressively damage metabolic processes that lead to dysfunction and disease. 
 
GCs also exhibit intense control over the function of immune cells during allostatic load. 
Counterintuitively, GCs induce both pro-inflammatory and anti-inflammatory effects on immune 
cells (Cruz-Topete and Cidlowski, 2015), likely determined by whether the type 1 or type 2 
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allostatic overload response has been activated. Anti-inflammatory effects of the GCs are carried 
out by both the adaptive immune system and the innate immune system. In the adaptive immune 
system, GCs trigger the apoptosis of basophils, eosinophils, and T cells (Sorrells and Sapolsky, 
2007). Further, the main pro-inflammatory transcription factors Nf-KB and AP-1 are inhibited by 
chronic GC action (De Bosscher et al., 2003). However, GCs are a known counter regulator of 
the inflammatory response. Indeed, other studies show GC action activates Nf-kB. Sub-
pathological increases in GCs from stress or peripheral administration increases Nf-kB activation 
and expression of the inflammatory cytokines IL-1β and TNF-α due to LPS administration 
(Munhoz et al., 2006, Munhoz et al., 2010). Thus, stress may not directly activate the 
inflammatory response, but modulate the response to an immune challenge or other stressor. 
Indeed, GCs increase the expression of the immune receptors Toll-like receptor (TLR) 2 and 4, 
which are heavily involved in pro-inflammatory signaling pathways (Cruz-Topete and 
Cidlowski, 2015). While these GC-immune system interactions clearly have a profound effect on 
how an individual responds to allostatic load, they also may represent a method that stress uses 
to communicate behavioral change in response to stress to the brain.  
 
Part of the response to stressful stimuli is behavior change to remove the individual from 
the dangerous threat approaching, which requires changes to nearly all behavioral circuits. Even 
fundamental behaviors, such as locomotor activity, are affected by GC action. The GC agonist, 
dexamethasone, reduces locomotor activity in novel situations (Menshanov et al., 2014). GC 
action has also been implicated in pathological behaviors as well. Dexamethasone also increases 
anxiety-like behaviors in zebrafish, a growing model for examining stress effects (Khor et al., 
2013). Similar anxiogenic effects have been observed in rodents following corticosterone 
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administration (Skorzewska et al., 2014). GC administration also causes GABA receptor 
dysfunction, a major neurotransmitter in the central nervous system. Chronic stress and GC 
elevation also reduces synaptic plasticity and dendritic arbors of neurons, a process that impairs 
cognition in other models (McKittrick et al., 2000). This could explain why increasing 
neurogenesis in the brain reduced anxiety-like behavior due to GC administration (Hill et al., 
2015). Furthermore, stress-induced anxiety-like behavior is tied to increases in the pro-
inflammatory cytokines IL-1β, TNF-α, and IL-6 mRNA. Knockdown of the IL-1 receptor 1 
(IL1R1), the biologically active IL-1 receptor, eliminate behavioral complications (Wohleb et al., 
2014). Some have hypothesized that activation of IL-1 is central to the stress response (Goshen 
and Yirmiya, 2009). This is because of the large effects IL-1 plays in regulating the stress 
response, especially in regulating the HPA axis. Specifically, IL-1 dramatically affects 
expression of CRF from the PVN (Kluger and Rivier, 1991, Berkenbosch et al., 1987). 
Additionally,  IL-1 has been found to be a critical mediator of behavioral change following stress 
exposure, as evidenced by the ability of anti-IL-1 therapies in preventing behavioral outcomes 
(Goshen and Yirmiya, 2009). Finally, GC action plays a crucial role in depression (Kim et al., 
2016), and, more importantly, memory. In mouse models of Alzheimer’s disease, inhibition of 
GC receptors improves memory and increases synaptic plasticity (Lante et al., 2015). In these 
models, GCs secretion is likely chronically elevated due to the neurotoxic stress, and thus 
allostatic load, from the protein aggregates amyloid β and Tau. In addition, treatment with GCs 
during development impaired memory during adulthood (Zeng et al., 2015). Other studies have 
shown that GCs act through oxidative stress to impair memory (Sato et al., 2010). However, GCs 
may only negatively affect memory retrieval tasks, as treatment with GCs immediately after 
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training in a variety of tasks actually improves memory (Roozendaal, 2002) demonstrating a 
central paradox of GCs in regulating behavior.  
 
As the other major stress hormone, the catecholamines have a similar distribution of 
effects on cellular pathways, the immune system and behavior. The catecholamines play a 
similar role to the GCs in mobilizing cellular energy, and are well known to be able in induce 
hyperglycemia, through activation of the β2-receptor (Barth et al., 2007). Hyperglycemia due to 
catecholamine signaling increases glucose utilization in certain tissues, and blocking adrenergic 
receptors with propranolol decreases aerobic glycolysis in the brain (Dienel and Cruz, 2016). 
Lipid metabolism is also affected by the catecholamines. Lipolysis from adipose tissue is 
commonly associated with catecholamine signaling (Nagayama et al., 2010). Further, perfusion 
of epinephrine into skeletal muscle increases palmitate release (Gjedsted et al., 2011). Indeed, 
this ability of the catecholamines to modify energy levels highly suggests that it plays an 
important role in regulating the allostatic overload response. 
 
In addition to the other effector tissues mentioned previously, immune cells also express 
adrenergic receptors and are susceptible to regulation by catecholamines (Bergquist et al., 1994). 
Much like the GCs, catecholamines have both pro-inflammatory, and anti-inflammatory 
properties, that are partially regulated by the specific adrenergic receptors activated (Barnes et 
al., 2015).Activation of adrenergic receptors on neutrophils initiates phagocytosis and histamine 
release in basophils (Madden et al., 1995). Further, catecholamines induce proliferation and 
differentiation of B and T cells of the adaptive immune system (Madden et al., 1995). Finally, 
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catecholamines affect the expression of pro-inflammatory cytokines. Blocking β2 and β3 
adrenergic receptors significantly reduced expression of TNF-α, IL-1β, IL-6, and CCL2 in rats 
(Hartung et al., 2014). In the brain, the β-AR agonist isoproterenol increases IL-1β and IL-6 
production in microglia isolated from hippocampal cultures (Johnson et al., 2013). IL-1 plays 
just as significant of a role in the catecholamine response to stress as it does to the GC response 
(Goshen and Yirmiya, 2009). Within the brain, propranolol blocks IL-1β release due to 
footshocks (Blandino et al., 2006). Blocking projections from the locus coeruleus by lesions, the 
main site of adrenergic input into the brain, prevents IL-1β increases following stress, further 
showing the involvement of the catecholamines in the IL-1 response to stress (Johnson et al., 
2005). Β-agonists also increase IL-6 production in the lungs due to air-pollution induced stress 
(Chiarella et al., 2014). Activation of the other adrenergic receptors, the α-adrenergic receptors, 
increases pro-inflammatory cytokine expression, and antagonists for these receptors reduce TNF-
α production (Spengler et al., 1994).  
 
 In addition to these effects on the immune system, the catecholamines also affect 
behavior through similar mechanisms as the glucocorticoids. Both α and β-AR antagonists are 
able to prevent anxiety-like behaviors following orexin-A, a hypothalamic peptide, 
administration (Palotai et al., 2014). This suggests that the hypothalamus, which begins HPA 
axis regulation, is quite sensitive to catecholamine signaling. The β-AR antagonist propranolol 
also reduces anxiety-like behaviors developed from cocaine use (Schank et al. 2008). 
Furthermore, propranolol decreases cognitive deficits and insulin resistance caused by 
corticosterone administration (Dobarro et al., 2013). However, β-AR stimulation may also be 
required for emotional learning, as inhibiting adrenal catecholamine secretion impairs memory 
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retention (Liu et al., 1999). Additionally, propranolol reduces freezing behavior following 
operant conditioning (Camp and Johnson, 2015). Clearly, the stress response has a wide array of 
effects on metabolism, the immune system, and nervous system that affect behavioral outcomes 
from stress. However, these effects work through a variety of mechanism, and how such 
disparate mechanisms get coordinated by the brain is another important consideration in how the 
stress response and allostatic load affect behavior. Given its role in regulating emotion, it is 
likely that the amygdala plays a central role as the main brain region involved in the stress 
response.  
 
Role of amygdala in allostatic load 
As the region that plays the greatest role in emotional and fear responses, the amygdala is 
particularly susceptible to physiologic modulation during stress, which is especially evident in 
scenarios such as post-traumatic stress disorder (PTSD; Hendrickson and Raskind, 2016). 
However, the amygdala also plays several essential roles in coordinating memory processes 
within other brain regions, such as the hippocampus (Bass et al., 2014).This combination role of 
the amygdala in both memory processes and the stress response makes it critical we understand 
the connections between these functions, especially as it relates to our understanding of 
mechanisms by which allostatic load leads to cognitive dysfunction in several neurological 
diseases. 
 
Although the amygdala was once primarily known for its role in emotional memories 
(McGaugh, 2004, Pelletier and Pare, 2004), recent technological advances, such as optogenetics, 
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have allowed us to discover the much larger role of the amygdala in cognitive processes in other 
regions of the brain (Lalumiere, 2014). In humans, damage to the amygdala causes deficits in 
recognizing specific emotions and fearful expressions on other faces (Adolphs et al., 1994, 
Adolphs et al., 2005). Further, the amygdala, specifically the basolateral amygdala (BLA) sub-
region, is critical to the development anxiety behaviors (Tye et al., 2011). In generalized anxiety, 
patients often present with disrupted connections within the amygdala, and from the amygdala to 
other regions (Etkin et al., 2009). Similar to general anxiety, social anxiety is due to reduced 
connections between the amygdala and the orbitofrontal cortex (Hahn et al., 2011).   
 
Due to the role of the amygdala in recognizing emotional states on faces, it is no surprise 
that the amygdala plays a central role in other forms of recognition memory. Stimulation of the 
BLA following training in the novel object recognition task has been shown to improve 
recognition memory formation (Bass et al., 2014) and inhibitory avoidance (Huff et al., 2013). 
This strengthening of recognition memory following BLA stimulation may be due to amygdala 
recruitment of the hippocampus in memory formation, as BLA stimulation potentiates activity 
and synchrony in hippocampal spiking, a process involved in the physiologic correlates of 
memory formation (Bass and Manns, 2015). Amygdalae to hippocampal projections are also 
important in learning during footshock conditioning experiments (Huff et al., 2016). The 
amygdala appears to play a particularly important role in the formation and retention of new 
memories, as infusion of oxotremorine (OXO), an acetylcholine receptor agonist, immediately 
after context or footshock training into the BLA improved retention, whereas OXO infusion into 
the hippocampus only affected contextual memory (Malin and Mcgaugh, 2006). Additionally, 
lesions made to the amygdala several days after a footshock training appear to have no effect on 
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memory retention, further suggesting the amygdala’s role in memory is during early formation of 
new memories (Liang et al., 1982). Biochemically, the stress hormones play a significant role in 
amygdala mediated memory processes (Pare, 2003).  
 
Stress causes a myriad of effects in the brain, and the amygdala is the central hub 
regulating these responses. The locus coeruleus (LC) is the site of the initial neurological inputs 
of stress in the brain (Benarroch, 2017), and it is also the primary norepinephrine input into the 
BLA (Pickel et al., 1974). Norepinephrine activity in the BLA plays an important role in 
memory. Norepinephrine activity affects memory processes throughout the brain and even 
neuromodulatory systems (Ferry and McGaugh, 2000). These effects may also rely on 
glucocorticoids, as application of GCs improves the excitability of BLA neurons, which could 
lead to improved memory (Duvarci and Pare, 2007). Similarly, administration of adrenergic 
agonists into the BLA in unstressed animals improves memory (Ferry et al., 1999). Inactivation 
of the BLA by lesioning prior to stress exposure eliminates memory impairment, which suggests 
the BLA plays a critical in both normal memory processes and stress induced changes in 
memory (Tripathi et al., 2017). Additionally, BLA, and the central nucleus of the amygdala 
(CeA), lesion during stress induces anxiety-like and depressive-like behaviors (Ventura-Silva et 
al., 2013, Ranjbar et al., 2017). Although acute stressors, and agonism of stress receptors, appear 
to facilitate memory formation, chronic stimulation of glucocorticoid receptors induces memory 
impairment (Nathan et al., 2004). A similar negative effect from chronic circulating 
catecholamines has been observed as well (Roozendaal et al., 2007). Combined with the research 
on the amygdala’s role in memory formation, these data suggest that the effects of stress on 
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memory are primarily mediated by a circuit that originates in the LC and projects to the 
amygdala, then out to other regions important for memory storage.  
 
 However, while the preceding mechanisms are all ways in which dynamic changes in a 
variety of systems regulate allostatic load, how these are coordinated together is still unknown. 
Further, a precise mechanism by which energy level regulates the preceding response has not 
been identified. While several energy exist, such as AMPK (Qi and Young, 2015) and mTOR 
(Albert and Hall, 2015), only the inflammasome complex is capable of sensing energy state and 
is already known to interact with the rest of the stress response systems. Indeed, AMPK and 
mTOR may act as signals that feed into the inflammasome as well, especially through 
autophagic flux (Wen et al., 2011, Bullon et al., 2016, Moon et al. 2015). 
 
The inflammasome as a regulator of the allostatic overload response 
 The inflammasome is a multimeric protein complex consisting of a sensor, an adaptor, if 
necessary, and caspase-1. It is this terminal cysteine protease, caspase-1, that is responsible for 
the main function of the inflammasome, the proteolytic conversion of pro-IL-1β to its active and 
secretable form (Thornberry et al. 1992). While caspase-1 is the functional component of the 
inflammasome, the other two proteins play an integral role in how the inflammasome performs 




 To date, two main classes of sensor molecules have been identified in canonical 
inflammasome activation, the nod-like receptors (NLRs) and the AIM2-like receptors (ALRs) 
(Lu and Wu, 2015). Their primary function is to sense specific molecular danger signals know as 
pattern-associated molecular patterns (PAMPs) or danger-associated molecular patterns 
(DAMPs). The NLRs are comprised of three domains, the first of which is either a pyrin domain, 
resulting in NLRPs, or CARD domain, known as NLRCs. Next is the NACHT domain for 
nucleotide binding, and, finally, a terminal leucine-rich repeat (LRR) domain (Ting et al., 2008). 
Like many other inflammasome proteins, the NLRs are susceptible to direct post-translation 
regulation. Nitric oxide is capable of nitrosylating NLRP3, a modification that inhibits 
inflammasome assembly (Mishra et al., 2012). Although 22 NLRs have been identified, only a 
small fraction of those are utilized in inflammasome complexes. The NLR most studied in 
relation to stress is NLRP3, however, several other NLRPs have been shown to regulate the 
inflammasome in variety of stress like conditions. For instance, osmotic stress from hypertonic 
conditions activates the NLRC4 inflammasome in macrophages (Ip and Medzhitov, 2015). 
Water avoidance stress inhibits the NLRP6 inflammasome in a CRH dependent manner (Sun et 
al., 2013).  
 
 The second component of the inflammasome complex is the adaptor molecule ASC. ASC 
contains two protein domains, a pyrin domain and a CARD domain (Masumoto et al., 1999). 
Primarily, ASC functions as a molecular adaptor, connecting the NLRs via their pyrin domain to 
caspase-1 via its CARD domain. This is essential to inflammasome assembly, and deletion of 
ASC eliminates inflammasome aggregation (Boini et al., 2014). In the cell, ASC is frequently 
observed in aggregated macromolecular specks (Proell et al., 2013). When activated, ASC forms 
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into long filaments located in the perinuclear space (Lu et al., 2014). Despite its simple function, 
ASC is also tightly regulated, much like the NLRs. It can be post-transcriptionally modified by 
phosphorylation (Hara et al., 2013) and ubiquitination (Guan et al., 2015), which affect its ability 
to form specks. Further, these modifications meaningfully affect inflammasome activity. 
Inhibition of the Syk kinase inhibited IL-1β production by ~50% due to the reduction of ASC 
phosphorylation (Lin et al., 2015).  Treatment with deubiquitination enzymes also impairs ASC 
oligomerization (Lopez-Castejon et al., 2013). 
 
 The final component of the inflammasome is the inflammatory caspase. These 
inflammatory caspases differ from apoptotic caspases, such as caspase-9, and display little to no 
apoptotic ability. Of the inflammatory caspases, the most studied is caspase-1. Caspase-1 
consists of a CARD domain, as well as p10 and p20 domains (Schroder and Tschopp, 2010). Of 
these, only the p20 domain represents the active proteolytic domain. As such, caspase-1 itself 
requires activation, and is auto-activated once aggregated into inflammasome specks and 
filaments (Guey et al., 2014). However, given the complex regulation of the NLRs and ASC, 
caspase-1 needs little additional regulation beyond this activation step. Genetically, at least 7 
human SNPs have been identified with the caspase-1 gene, and all of them result in a reduced 
enzymatic activity phenotype (Luksch et al., 2013). Yet, in instances of caspase-1 inhibition, IL-
1β can still be produced, as caspases 4, 5, and 12 have all been shown to form into 
inflammasome complexes as well (Sanders et al., 2015, Martinon et al., 2002). Although 
caspase-1 cleaves a very specific sequence, the Y_AD amino acid pattern, where the second 
amino acid in the target sequence can be a variety of amino acids, it can act on a wide array of 
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additional protein, including IL-18 (Denes et al., 2012) and glycolytic enzymes (Shao et al., 
2007).  
 
 The finding that caspase-1 can also act on glycolytic enzymes suggests that it plays a 
greater role in metabolism than previously thought. Indeed, a large body of evidence suggests 
that the inflammasome is major energy sensor, and that it acts as a “metabolic stress” sensor in 
the cell (Donath, 2011, Schroder et al., 2010). Although the list of danger signals capable of 
activating the inflammasome continues to grow, many of them utilize common mechanisms that 
all relate to cellular energy status in some way. Additionally, many energy substrates are able to 
regulate the inflammasome directly or indirectly.  
 
 Perhaps the greatest known activator of the inflammasome is cellular reactive oxygen 
species (ROS) (Latz et al., 2013). ROS can be generated by a variety of mechanisms; however, 
mitochondrial derived ROS are particularly damaging and are involved in stress signaling 
(Sabharwal and Schumacker, 2014). Due to the generation of ROS from mitochondria and the 
involvement of the electron transport chain in developing ROS (Zorov et al., 2014), they are 
commonly thought of a signals of excess energy. In fact, application of the main energy currency 
of the cell, ATP, to cell cultures induces ROS generation and activates the inflammasome (Cruz 
et al., 2007). However, even non-energetic compounds utilize ROS as a danger signal to activate 
the inflammasome. In the lungs, the common respiratory irritants asbestos and silica generate 
ROS via the NADPH oxidases that is activates the inflammasome, suggesting that these 
compounds induce metabolic disturbances that cause mitochondrial dysfunction and an increase 
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of intracellular energy substrates. Another common cellular stress signal is endoplasmic 
reticulum (ER) stress. While this cellular subcompartment is not itself involved in energy 
maintenance, ER stress has been shown to activate the inflammasome in an ROS dependent 
fashion (Menu et al., 2012). As ER stress shuts down certain metabolic pathways, it also leads to 
an increase in intracellular energy. While this brief review certainly highlights the ways in which 
a variety of danger signals act through metabolic messengers, the topic has previously been 
reviewed in depth elsewhere (Tschopp and Schroder, 2010). 
 
 Another common activator of the inflammasome that shows how the inflammasome is 
fundamentally an energy sensor is ATP. However, it is not only does ATP activate the 
inflammasome, but purinergic compounds in general. Both uric acid and ATP have been shown 
to activate the inflammasome during hepatic steatosis (Iracheta-Vellve et al., 2015). The 
extracellular ATP receptor, P2X7, is mechanistically involved in ATP-induced inflammasome 
activation (Luna-Gomes et al., 2015). The translocation of ATP from intracellular to 
extracellular is also due to a mechanism involving cellular energy levels. ATP is commonly 
effluxed from the cell when energetic pathways are at capacity. Glycolysis can be inhibited 
during the responses to energy state, due to feedback from downstream metabolites and redox 
state. When glycolysis is artificially inhibited by 2-deoxyglucose intracellular ATP decreases, 
leading to mitochondrial dysfunction and inflammasome activation (Nomura et al., 2015). Fatty 
acids also reduce glycolysis in a similar manner, providing a mechanism by which obesity could 
induce stress and abnormal behavior. Additionally, purinergic compounds other than ATP and 
uric acid are capable of activating the inflammasome. cAMP has been shown to be involved in 
calcium influx related inflammasome activation (Lee et al., 2012) and is increased by adrenergic 
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receptor activation during energy mobilization. Further, adenosine activates the inflammasome 
both alone and during hypoxic stress (Chiu et al., 2012, Chiu et al., 2014). In this scenario, 
adenosine likely comes from damaged cells that have released intracellular metabolic 
compounds into the extracellular space, such as ATP, ADP, or cAMP.  
 
 Finally, macromolecules that supply energy from the diet affect inflammasome activity. 
The fatty acids play a specific role in stress, and also have specific effects on the inflammasome. 
The saturated fatty acid palmitic acid activates the inflammasome (Wen et al., 2011). SFAs such 
palmitic acid is abundant in obesogenic diets, and is also the main storage fatty acid that is 
released during stress. However, replacement of palmitic acid with oleic acid prevented 
inflammasome activation (Finucane et al., 2015). Palmitic acid also primes the inflammasome, 
the process of increasing transcription of inflammasome related genes, via a TLR4 dependent 
mechanism (Reynolds et al., 2012). The lipotoxic fatty acid derivative ceramide also activates 
the inflammasome in diseases of excess energy such as obesity and diabetes (Vandanmagsar et 
al., 2011). Glucose is also an activator of the inflammasome, and does so in a dose-dependent 
manner in cell culture (Feng et al., 2016). Hyperglycemia also induces priming of the 
inflammasome (Chen et al., 2017). As previously mentioned, hyperglycemia is one of the many 
activators of the inflammasome that signals its high-energy state via increasing cellular ROS (Shi 
et al., 2015). 
 
 The commonality between many of these activators of the inflammasome is that they all 
act as a signal of a hyperenergetic state. The counterfactual idea, that low energy states inhibit 
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the inflammasome, is indeed true, as would be expected based on the allostatic response to stress, 
further demonstrating how the inflammasome regulates the allostatic response to stressors. 
Starvation and fasting, involuntary or voluntary, represent the most extreme cases of energy 
deprivation known. Given that the type 1 allostatic response is characterized by a low energy 
state, it would be expected that fasting can reduce inflammasome activation. During, ischemic 
stroke inflammasome activation is prevented by intermittent fasting, which provides evidence for 
this hypothesis (Fann et al., 2014). This effect is linked to reduction of mitochondrial ROS via 
increased superoxide dismutase activity (Traba et al. 2017). This effect of fasting on the 
inflammasome has been observed in human subjects, demonstrating the translatability of this 
idea (Traba et al., 2015). During starvation, the body switches from a glycolytic state to one of 
fatty acid metabolism. In the process, large increases in ketone bodies are produced to fuel 
tissues that cannot directly burn fatty acids such as the brain. The ketone body beta-
hydroxybutyrate is a potent inhibitor of the inflammasome (Youm et al., 2015). This effect is 
apparent during ketogenic dieting (Goldberg et al., 2017). Even sodium butyrate, the short chain 
fatty acid, reduces inflammasome activity (Bian et al., 2017). The omega-3 fatty acids are 
essential but are also largely metabolically inert and provide little energy. Given this, inclusion 
of omega-3 to the exclusion of other, energy containing, fatty acids could produce a caloric 
deficit. Given this, it would be expected that the omega-3s also inhibit the inflammasome. 
Indeed, the omega-3s do just this, and utilize their g-protein coupled receptors, GPR120 and 
GPR40, to carry out this function (Yan et al., 2013). Aerobic glycolysis is frequently associated 
with high, immediate, energy demand such as in intense physical activity, which also is a type of 
stress that would be expected to induce the type 1 allostatic response due to the high usage of 
energy. A product of this type of metabolism, lactate, also negatively regulates the 
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inflammasome (Hoque et al., 2014). Given the plethora of data it is easy to see how the 
inflammasome acts an energy sensor. However, is this regulation by energy state reflected in 
behavioral outcomes of inflammasome activity? 
 
 IL-1β, and the inflammasome that activates it, are central to many biobehavioral 
processes. Not only does it play a role in memory, anxiety, and depression, but it can regulate 
these processes in a variety of ways during stress. As with many inflammatory processes, 
activation of IL-1β during specific stressors is beneficial, however, aberrant inflammasome 
activation can prove to be detrimental to cognition. Indeed, the inflammasome appears to 
regulate these three brain functions in response to allostatic stressors. 
 
 As mentioned, ATP represents a high-energy state that would induce the type II allostatic 
response and inflammasome activation. During chronic unpredictable stress animals were shown 
to have increased inflammasome activation that is coupled to increased anxiety-like and 
depressive-like behaviors in mice (Yue et al., 2017). The negative effect on behavior is 
eliminated by P2X7 knockout, showing a link between the high energy, type II allostatic 
response and behavioral dysfunction. This same effect is also evident after acute restraint stress 
(Iwata et al., 2016), further showing that stress effects are less reliant on intensity and duration, 
but energy sensing. Indeed, in ad lib fed mice the mobilization of energy during chronic stress 
can cause meaningful increases in local energy levels. As such it would expected that stress itself 
in such animals can induce behavioral abnormalities, and that is indeed the case (Wong et al., 
2016). This also causes changes in the gut microbiome that could lead to increased energy 
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harvesting from the diet and exacerbate inflammasome activation (Wong et al., 2016). 
Menopause, and the animal model correlate ovariectomization, causes increases in body weight 
(Blaustein et al., 1976). This increase in energy consumption that leads to overweight can also 
increase inflammasome activation and anxiety-like and depressive-like behaviors following 
ovariectomy (Xu et al., 2016). Further evidence that high energy states affect anxiety and 
depressive behaviors comes from high-fat diet models of obesity, where chronic feeding can 
induce anxiety-like behavior (Sivanathan et al., 2015). Additionally, exogenous administration of 
fatty acids to ad lib fed mice induces anxiety-like behaviors (Moon et al., 2014). Finally, signals 
of low energy states improves anxiety-like behaviors as expected based on the response to 
allostatic load. The ketone body β-hydroxybutyrate decreases anxiety-like behaviors in mice 
(Yamanashi et al., 2017). Fasting is also effective at reducing IL-1β induced behavioral effects 
(Joesting et al., 2014). In human subject with metabolic stress due to obesity, caloric restriction 
significantly reduces anxiety levels (Perez-Cornago et al.,2014). Caloric restriction is just as 
effective at reducing anxiety-like behaviors as well (Levay et al., 2007). Taken together, these 
data show that even stressors that would not be considered metabolic in nature affect behavior 
via effects on energy level. 
 
 Perhaps more so than anxiety and depressive behaviors, cognition is more strongly 
regulated by energy status and the inflammasome. During occlusion stress in vascular dementia 
models, mice exhibit significant oxidative stress, memory impairment, and inflammasome 
activation (Du et al., 2017), suggesting that this form of stress acts as a type II allostatic stressor 
that negatively regulates cognition, due to excess energy substrates released during hypoxic 
damage. This effect has also been seen in acute hypoxia (Chiu et al., 2012). In fact, food 
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restriction during ischemia is protective and improves memory (Roberge et al., 2008). Thus, 
lowering systemic energy levels can improve memory even during extreme acute stressors. Other 
stressors have produced similar effects. High-fat diet-induced metabolic stress impairs memory 
in an IL-1β dependent fashion (Sobesky et al., 2014). This effect is mediated by glucocorticoids, 
showing how the stress response is indeed active during this type of metabolic stressor, and that 
energy levels can significantly affect behavioral outcomes in relation to stress (Sobesky et al., 
2016). Just as high energy levels from dietary sources can cause behavioral impairment, caloric 
restriction prevents memory deficits from traumatic brain injury, further showing how low 
energy levels improves behavioral outcomes during stress (Rich et al., 2010). Ketogenesis during 
caloric restriction is a very likely mediator of these beneficial effects. In Alzheimer’s disease 
models, mice typically present with extreme mitochondrial dysfunction that could lead to excess 
cellular energy due to the inability to utilize mitochondria for energy generation. However, 
ketone administration in mouse models of Alzheimer’s has proven to be an effective treatment 
for cognitive impairment (Yin et al., 2016). Feeding ketone esters also produces similar effects in 
other Alzheimer’s models (Kashiwaya et al., 2013). This suggests that actual low energy levels 
are not necessary to induce a type 1 allostatic overload response, but just the presence of 
evolutionary mediator of starvation. Other methods of lowering energy levels are also effective 
at improving behavioral outcomes during stress. Exercise, itself a stressor, improves cognition 
following restraint stress (Kwon et al., 2013). Exercise is a unique stressor, in that it produces 
incredibly beneficial effects over time while inducing acute stress effects as well, however, using 






 Given this evidence we believe that the inflammasome is a molecular protein complex 
that acts as the energy sensor of the stress response. This is because of the various inputs by the 
classical stress response, such as the catecholamines and glucocorticoids in regulating the 
expression and activating the inflammasome. Further, the inflammasome responds to many 
cellular marker of energy state from ketone bodies developed during starvation to fatty-acids 
provided by high-calorie diets. Even cellular markers of energy state, such as the redox state of 
the cell, and ATP metabolites have been shown to regulate the inflammasome. Finally, the 
inflammasome is essential for proper IL-1β activation, and IL-1 is absolutely crucial for the 
behavioral response to stress (Goshen and Yirmiya, 2009). Truly, every aspect of the stress 
response is in some way directly or indirectly related to the inflammasome, demonstrating its 
primacy in regulating the stress response. However, research directly testing the hypothesis that 
energy level regulates the inflammasome in the brain to modify behavior has yet to be 
conducted. The following chapters will examine how the inflammasome responds to low energy 
levels during fasting, high-energy levels during hypercaloric feeding, and mechanisms by which 
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CHAPTER 2: LOW ENERGY LEVELS FROM ACUTE FASTING INHIBITS 
CENTRAL CASPASE-1 ACTIVITY REDUCING ANXIETY-LIKE BEHAVIOR AND 
INCREASING NOVEL OBJECT AND OBJECT LOCATION RECOGNITION DURING 
THE TYPE 1 ALLOSTATIC OVERLOAD RESPONSE 
Abstract 
Inflammation within the central nervous system (CNS) is frequently comorbid with anxiety. 
Importantly, the pro-inflammatory cytokine most commonly associated with anxiety is IL-1β. 
The bioavailability and activity of IL-1β is, in part, regulated by caspase-1-dependent proteolysis 
vis-a-vis the inflammasome. Thus, interventions aimed at regulating the activation or activity of 
caspase-1 should reduce anxiety especially in states that foster IL-1β maturation. Further, 
inducing low energy levels should represent an intervention capable of reducing caspase-1 
activation through its effects in regulating the response to allostatic overload. Here, we show that 
a 24 h fast in mice reduces the activity of caspase-1 in whole brain and in prefrontal cortex, 
amygdala, hippocampus, and hypothalamus by 35%, 25%, 40%, 40%, and 40% respectively. A 
24 h fast also results in a 40% reduction in anxiety-like behavior and a 21% and 31% increase in 
novel object and object location recognition, respectively, at 24 hours following fasting. ICV 
administration of the caspase-1 inhibitor biotin-YVAD-cmk reduces caspase-1 activity in the 
prefrontal cortex and amygdala by 55%, respectively, and results in a 64% reduction in anxiety 
like behavior. Importantly, when caspase-1 or IL1-R1 knockout (KO) mice are fasted, no fasting-
dependent reduction in anxiety-like behavior is observed. Taken together these results indicate 
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that fasting reduces anxiety-like behavior and improves memory by a mechanism tied to 
reducing caspase-1 activity throughout the brain, thus suggesting that low energy levels do 
indeed promote type 1 allostatic overload responses and beneficial behavioral adaptation.  
 
Introduction 
In the cell, the cysteine-dependent protease caspase-1 is critical to the maturation of pro-
IL-1β to its secretable form (Cerretti et al., 1992, Thornberry et al., 1992). In order for caspase-1 
to become active, it requires scaffolding within the multi-protein containing inflammasome 
(Martinon et al., 2002). Canonically, activation/danger signals are sensed by the Nod-like 
receptor (NLR) family or the absent in melanoma 2-like (AIM2) receptors. The most well 
studied of these caspase-1 activators being NLRP3 (NOD-, LRR, and pyrin domain-containing 
3), which is normally in an auto-repressed state (Sutterwala et al., 2014). Relief of LRR-
mediated auto-repression exposes the central nucleotide-binding domain (NBD) and the N-
terminal pyrin domain (PYD). NLRP3 oligomerization via a homotypic NBD interaction results 
in the recruitment of the PYD and caspase recruitment domain (CARD) containing adapter 
protein (ASC) that then recruits pro-caspase-1 (Lu et al 2014, Proell et al 2013). Clustering of 
pro-caspase-1 in the assembled inflammasome results in auto-processing-dependent activation of 
caspase-1 and cleavage/maturation of pro-IL-1β (Salvesen and Dixit 1999, Shi 2004) 
 
The pro-inflammatory cytokine IL-1β is a well-recognized anxiogenic (Rossi et al, 2012, 
Murray et al., 2013, Chiu et al., 2014). Most work examining the behavioral effects of IL-1 are 
developed from the sickness behavior paradigm in which infection, often modelled by peripheral 
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lipopolysaccharide (LPS) administration, induces brain-based production of IL-1 (Dantzer et al 
2008). While agreement exists as to the importance of brain-generated IL-1 to certain types of 
behavioral dysfunction, the mechanisms producing IL-1β in the brain are not clearly understood. 
IL-1β is normally present in the brain, but the appearance of IL-1β is generally tied to 
inflammation-inducing conditions (Spulber, 2009). In support, pharmacological and genetic 
therapies targeting the IL-1 arm of the immune system are proven effective at treating some 
neurodegenerative conditions. In contrast, adversely impacting brain-based IL-1β concentration 
or signaling appears to disrupt memory in animals without disease, implicating a role for IL-1β 
in the healthy state (Goshen et al. 2007, Yirmiya et al., 2002.). Indeed, IL-1 has also been 
identified as a critical regulator of the stress response (Goshen and Yirmiya, 2009), which would 
provide a connection between the inflammasome and the response to allostatic overload. 
 
As a group, anxiety disorders are among the most common mental illnesses suffered by the 
general population (Somers et al., 2006). The etiology of anxiety disorders is not known but both 
genetic and environmental stressors appear to contribute (Markovitz et al., 2015, Otowa et al., 
2013, Sakolskyet al., 2012). Increasingly, inflammatory conditions, including childhood obesity, 
adult obesity, metabolic syndrome and type 2 diabetes (T2D) are co-morbid with anxiety 
disorders (Petry et al., 2008, Bankier et al., 2008, Smith et al., 2012). Since low-grade systemic 
inflammation is a key feature of the diabetes disease spectrum, it is hypothesized that 
inflammation is important to the psychophysiology of anxiety disorders. In fact, various SNPs in 
genes coding for both IL-1β and IL-1R2 have been linked to increases in both state and trait 
anxiety (Miaskowski et al., 2015). Given that fasting is known to reduce some of the sickness 
symptoms associated with the peripheral administration of IL-1β (Joesting et al., 2014), we 
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sought to show, that in the healthy state, fasting has a beneficial impact on anxiety. Further, this 
model would also demonstrate that low energy levels regulate behavioral responses via 
mechanisms involving inflammasome regulation. The translational rational for this idea is that 
calorie restriction in humans, whether achieved through intermittent fasting (IF), alternate-day 
fasting or starvation, is associated with self-perceived improvements in well-being. 
 
Methods 
Materials- All reagents were purchased from Sigma-Aldrich (St Louis, MO).  
 
Animals - Animal use was performed according to protocols approved by the Institutional 
Animal Care and Use Committee at the University of Illinois. Wild-type C57BL/6J (WT), 
interleukin (IL)-1 Receptor 1 (IL1R1), and Caspase-1 (Casp-1) KO mice were originally 
purchased from The Jackson Laboratory (Bar Harbor, ME) and bred in-house. Mice were 
provided food and water ad libitum in standard shoebox cages unless otherwise stated. Animals 
were group housed (up to 8 per cage), then moved to individual housing the day prior to testing 
unless noted otherwise. Housing temperature (72 °F) and humidity (45–55%) were controlled, 
and a 12/12h reversed dark-light cycle (2200–1000 h) was maintained. Animal behavior was 
video recorded using a Sony HDR-XR500V Night Shot capable video camera (Tokyo, Japan). 
All mice used were males, between 9 and 15 weeks of age. All behavior testing was completed 




Fasting, refeeding, body weight, and food intake- As we have described (Lavin et al., 
2011), 2 days prior to fasting, mice were individually housed. Fasting was initiated by placing 
mice in a new cage without food but with ad libitum water. Mice were fasted for 24 h beginning 
within 1 hour of the beginning of the dark cycle. Fed mice were treated identically to fasted mice 
but were provided ad libitum access to food (fed mice). For refeeding, fasted mice were provided 
ad lib access to food immediately following the 24 hour fasting period, and fed mice were 
continued on ad lib feeding. Mouse weight was recorded at the time points indicated using an 
Ohaus Adventurer Pro digital scale (Parsippany, NJ). Food weight was measured from petri 
dishes placed inside mouse cages. 
 
Locomotion- Spontaneous locomotor activity was measured as we have previously 
described (Lavin et al., 2011, York et al., 2012). Mice were video recorded in modified home 
cages for the entirety of the active cycle using a Sony Night Shot capable video camera (Minato-
ku, Tokyo) Distance moved was quantified using Noldus Information Technology EthoVision 
XT 7 automated tracking software (Leesburg, VA).  
 
Injectables- Biotin-YVAD-cmk (YVAD) was obtained from AnaSpec (Fremont, CA). 
Intracerebroventricular (ICV) YVAD was administered at a dose of 150 ng/mouse. 
 
Determination of caspase-1 activity- Caspase-1 activity was determined as we have 
previously described (Chiu et al. 2012). Briefly, mice we euthanized with CO2 then 
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transcardially perfused with ice cold PBS. Brains were removed and brain regions were excised 
using a Mouse Brain Slicer (Zivic Insttruments, Pittsburgh, PA). Samples were immediately 
placed in liquid nitrogen and then freeze fractured using a Qiagen Tissuelyser II (Valencia, CA)  
in a buffer containing 50 mM CaCl, 10% glycerol, 1 mM DTT, 1 mM EDTA, 1 mM bestatin, 1 
mM pepstatin, 1 mM 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride and 50 mM 
HEPES, pH 7.4. Lysates were clarified at 16,000g for 15min at 4°C and the supernatant protein 
concentrations determined using the Bio-Rad DC Protein Assay (Hercules, CA) and a BioTek 
ELx800 Absorbance Microplate Reader (Winooski, VT). Supernatant protein concentrations 
were normalized with reaction buffer. Caspase-1 activity was determined colorimetrically in the 
clarified lysates using the caspase-1 substrate Ac-YVAD-p-nitroaniline (p-NA) (Enzo Life 
Science, Farmingdale, NY) at a final concentration of 4mM. Substrate incubation was at 37 °C 
for the times indicated. Moles of p-NA liberated was determined by a standard curve ranging 
from 0.075 to 0.3 mM p-NA (Enzo Life Science, Farmingdale, NY). Caspase-1 activity was 
calculated as (Δ[p-NA]/Δ time)/(total protein). Results are expressed as nM p-NA/min/µg of 
protein. 
 
 ICV Surgeries- As we have described (Johnson, D et al., 2007; Chiu et al., 2012) mice 
were deeply anesthetized with an IP injection of sodium ketamine hydrochloride 
(80mg/mL)/xylazine (12mg/mL) solution. The top of the skull was shaved to remove fur and 
animals were then placed in a David Kopf Instruments stereotaxic device (Tujunga, CA). 
Surgical site was swabbed three times with betadine solution and then with 70% ethanol. A small 
hole was made at 0.6 mm posterior and 1.5 mm lateral to the bregma. For behavioral 
experiments a Plastics One mouse-specific brain infusion cannula was inserted and fixed to the 
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skull with Plastics One cyanoacrylate gel adhesive and protected by a Plastics One guard. Mice 
were allowed to recover a minimum of three days before experimentation.  
 
Activated caspase-1 labeling- Following fasting, mice were deeply anesthetized with 
ketamine/xylazine (80mg/kg/ 12mg/kg) then were injected with 100 ng of biotin-YVAD-cmk 
ICV using a microinjection unit attached to a Kopf sterotaxic. 2 Hours following biotin-YVAD-
cmk injection mice were euthanized using CO2 and perfused with ice cold PBS followed by 4% 
paraformaldehyde. Brains were sectioned at 1.5 and 3.5 mm from the interaural coronally using a 
Mouse Brain Slicer (Zivic Insttruments, Pittsburgh, PA). Slices were fixed in 4% 
paraformaldehyde for 24 hours then paraffin embedded. 5μm slices from the two sections were 
blocked with hydrogen peroxide (Peroxidazed (PX968)) and labeled with SS HRP Label (4+ 
Strep HRP Label (HP604)), stained with liquid 3.3’-diaminobenzidine (DAB) chromogen (IP 
FLX DAB (IPK5010)), counterstained with hematoxylin (Cat Hematoxylin (CATHE)) and 
mounted and cover-slipped with the BioCare IntelliPATH. The entire slide was imaged at 40x 
with a NanoZoomer 2.0-HT (Hamamatsu, Bridgewater, NJ). Area of staining was measured by 
color thresholding in ImageJ (National Institute of Health) using a macro (sup figure. 1.) by a 
blinded observer. 
 
Quantitative PCR (qPCR)- As we have described (York et al., 2012), animals were 
transcardially perfused with 30 mLs of ice cold PBS and RNA isolated from homogenized 
tissues using Qiagen RNeasy Lipid Tissue Mini Kits (Valencia, CA). RNA was reverse 
transcribed using the Applied Biosystems High-Capacity cDNA Reverse Transcription Kit. The 
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TaqMan Gene Expression primers used were [IL-1β: mm00434228_m1, caspase-1: 
mm00438023_m1, nlrp3: mm00840904_m1, pycard: mm00445747_g1]. qPCR was performed 
on a Applied Biosystems 7900 HT Fast Real-Time PCR System using Applied Biosystems 
TaqMan Universal PCR Master Mix. To compare gene expression, a parallel amplification of 
endogenous RPS3 (Mm00656272_m1) was performed. Relative quantitative evaluation of target 
gene to RPS3 was performed by comparing ΔCts, where Ct is the threshold concentration.  
 
Quantification of IL-1β protein- Regional IL-1β was determined colorimetrically using a 
Quantikine ELISA kit from R&D Systems.  The minimum detectable level was measured to be 
0.46-4.8 pg/mL. Brain regions from 3 mice were pooled and frozen in liquid nitrogen, then 
freeze fractured in a buffer containing 50 mM CaCl, 10% glycerol, 1 mM DTT, 1 mM EDTA, 1 
mM bestatin, 1 mM pepstatin, 1 mM 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride 
and 50 mM HEPES, pH 7.4. Lysates were clarified at 16,000xg for 15 min. Supernatant protein 
concentrations were determined using the Bio-Rad DC Protein Assay (Hercules, CA). IL-1β was 
determined in 50 uL of supernatant. Data is expressed as pg/mg total protein. 
 
Elevated Zero Maze- As previously described (Kaczmarczyk et al. 2013), a zero maze 
consisting of two walled arms (14 cm) and 2 open arms was under white light illumination. Mice 
were placed in one of the high walled arms to begin testing and video recorded for 5 min. Time 
spent in the non-high wall area (open arm) was quantified using Noldus Information Technology 
EthoVision XT 7 automated tracking software (Leesburg, Va). Data is expressed as % time in 
the open arms. 
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Novel Object Recognition- Novel object recognition was examined as previously 
described (Chiu et al. 2012, York et al. 2012).  Mice were placed in a rat cage-sized arena (26 cm 
× 48 cm × 21 cm) containing two identical objects on opposite ends of the arena (training). After 
30 minutes, objects were removed and cleaned and sanitized with ethanol.  Testing was initiated 
2, 24, and 48 hours following the end of training.  During testing, two objects were replaced in 
the cage, one seen during training (familiar object) and one unfamiliar object (novel object). A 
new novel object was introduced during each testing period. Object investigation was video 
recorded for 5 min and evaluated by a blinded observer. Novel and familiar object % 
investigation was calculated by dividing the time spent examining each object by the total object 
investigation time. 
 
Object Location Recognition- Novel object location recognition was assessed in a method 
adapted from previously described novel object recognition test (Chiu et al. 2012, York et al. 
2012). Briefly, mice were placed in a large rat-sized cage (26 cm x 48 cm x 21 cm) arena with 
spatial cues marked on three sides.  During the training phase, two identical objects were 
presented to the animal on one side of the arena.  After 30 minutes of training, the objects were 
removed from the testing arena and sanitized with ethanol.  Testing was initiated 2, 24, and 48 
hours following the end of the training phase.  During testing, one of the objects was placed in 
the same location as during training (familiar location), and the other object was placed on the 
opposite end of the arena (novel location). A new novel location was chosen for each testing 
period.  Investigation was video recorded for 5 min and evaluated by a blinded observer. Novel 
and familiar location % investigation was calculated by dividing the time spent examining each 
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location by the total investigation time to determine the degree to which the mouse investigated 
the novel location. 
 
Statistics - Data are expressed as mean ± SEM. Analysis was conducted using Sigma Plot 
11.2 (Systat Software, Chicago, IL). To test for statistical differences, one-way and two-way 
ANOVAs were used as indicated. Novel object recognition and object location recognition were 
analyzed using one-sample t-test comparing novel object preference to a change level of 0.5. 
Data were transformed where necessary to attain normality or equal variance. Post-hoc 
comparison used Tukey’s test. Statistical significance was determined as p<0.05. 
 
Results 
Fasted mice weigh less; eat more, but move the same distance as fed mice. Mice were 
examined after a 24 h fast and then 24 h after being refed. Table 2.1 shows that when mice are 
fasted (0-24 h) they are 19% lighter than mice allowed ad libitum access to food. During the 
period of no food (0-24 h), fasted mice moved a similar distance when compared to fed mice. 
During the refeeding period (24-48 h), fasted mice ingested 19% more food and gained 17% 
more weight. Locomotor activity was similar in fasted and fed mice during the refeeding period 
(24-48 h). 
 
Fasting reduces caspase-1 activity in the brain. With respect to neuroimmunity, calorie 
restriction appears to be anti-inflammatory (Lavin et al., 2011; Joesting et al., 2014) providing 
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resistance to sickness symptoms generated by exposure to LPS (MacDonald et al., 2011). To 
determine if fasting impacted caspase-1, enzymatic activity was measured in mouse whole brain 
and brain regions after a 24 h fast. Fig. 2.1A shows that fasting reduced caspase-1 activity by 
35% (nM/min/µg protein fed vs. fasted, 1.09 ± 0.12 vs 0.71 ± 0.09 , p<0.001) in whole brain and 
by 25% (nM/min/µg protein fed vs. fasted, 0.733 ± 0.06 vs. 0.49 ± 0.07, p=0.016), 40% 
(nM/min/µg protein fed vs. fasted, 0.65 ± 0.14 vs. 0.33 ± 0.06), 42% (nM/min/µg protein fed vs. 
fasted, 0.44 ± 0.09 vs. 0.23 ± 0.04, p=0.49)  and 38% (nM/min/µg protein fed vs. fasted, 1.32 ± 
0.14 vs. 0.75 ± 0.14, p=0.007) in prefrontal cortex, amygdala, hippocampus and hypothalamus, 
respectively. To better understand the morphological location of caspase-1 activity in the brain, 
activated caspase-1 was labeled in fed and fasted mice. Fig. 2.1 B demonstrates, in a 
representative fashion, where caspase-1 activity is localized regionally. Fig.2.1C shows that 
fasting reduced active caspase-1 labeling by 71% (% area stained/100 cells fed vs. fasted, 3.48 ± 
0.71 vs. 0.96 ± 0.44), 88% (% area stained/100 cells fed vs. fasted, 2.68 ± 0.13 vs. 0.38 ± 0.06), 
66% (% Area stained/100 cells fed vs. fasted 1.61 ± 0.48 vs. 0.38 ± 0.13) and 55% (% Area 
stained/100 cells fed vs. fasted, 2.22 ± 0.22 vs. 1.08 ± 0.33) in prefrontal cortex, amygdala, 
hippocampus and hypothalamus, respectively. Table 2.2 shows that fasting significantly reduced 
IL-1β gene expression in whole brain and in prefrontal cortex, amygdala and hypothalamus 
(Table 2.2). No change was seen in gene expression for caspase-1 or NLRP3. A decrease in 
pycard expression was observed in the prefrontal cortex and in the hypothalamus of fasted mice. 
Fig. 2.1D shows no differences in IL-1β protein levels between fed and fasted mice.  
 
Fasting lessens anxiety-like behaviors and improves memory. Fasted mice and fed mice 
were examined for changes in prefrontal cortex, amygdala and hippocampus sensitive behaviors. 
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In the elevated zero maze, fasted mice spent 70% (fed vs. fasted, 24.41% ± 2.53 vs. 35.07% ± 
1.596, p=0.002; Figure 2.2A) more time in the open than unfasted mice. Locomotor activity 
during elevated zero maze testing was comparable between fasted and fed mice (fed vs. fasted, 
2234.67 cm ± 254.45 vs. 2435.62 cm ± 220.71, p=0.557; Figure 2.2B). In the novel object 
recognition (NOR) task fed and fasted mice investigated the novel object similarly at 2 h post-
training, which immediately followed fasting (fed vs. fasted, 62.8% ± 2.23 vs. 68.06% ± 1.82, 
p=0.089; one-sample t-test: fed- p<0.001, fasted- p<0.001; Figure 2.2C). At 24 h post-training, 
fasted mice investigated the novel object 21% (fed vs. fasted, 52.98% ± 2.28 vs. 64.34% ± 3.78, 
p=0.028; one-sample t-test: fed- p=0.211, fasted- p=0.007; Figure 2.2C) more than fed mice. Fed 
and fasted mice investigated the novel object comparably after 48 h post-training (fed vs. fasted, 
55.88% ± 4.89 vs. 47.62% ± 5.58, p=0.284; one-sample t-test: fed- p=0.268, fasted- p=0.683; 
Figure 2.2C). In the object location recognition (OLR) task, fed and fasted mice investigated the 
object in the novel position similarly at 2 h post-training (fed vs. fasted, 60.33% ± 3.93 vs. 
69.09% ± 1.96, p=0.066; one-sample t-test: fed- p=0.034, fasted- p<0.001; Figure 2.2D). At 24 h 
post-training, the fasted mice investigated the object in the novel position 32% (fed vs. fasted, 
49.21% ± 1.43 vs. 64.93% ± 2.81, p<0.001; one-sample t-test: fed- p=0.598, fasted- p=0.001; 
Figure 2.2D) more than fed mice. As with NOR, fed and fasted mice investigated both novel and 
familiar similarly after 48 h after training (fed vs. fasted, 46.08% ± 3.51 vs. 48.94% ± 2.69, 
p=0.529; one-sample t-test: fed- p=0.801, fasted- p=0.954; Figure 2.2D). 
 
The caspase-1 inhibitor, YVAD, reduces caspase-1 activity in the brain and anxiety-like 
behavior. To determine if pharmacologic inhibition of caspase-1 activity mimics fasting, mice 
were ICV injected with the caspase-1 inhibitor YVAD. Table 2.3 shows that mice administered 
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YVAD have no difference in weight, food intake or locomotor activity when compared to saline 
injected control mice. Caspase-1 activity was measured 24 hours after YVAD injection. Figure 
2.3A shows that YVAD reduced caspase-1 activity by 55% (nM/min/µg protein saline vs. 
YVAD, 1.69 ± 0.21 vs. 0.76 ± 0.21, p=0.014) and 54% (nM/min/µg protein saline vs. YVAD, 
1.16 ± 0.27 vs. 0.54 ± 0.06, p=0.012) in the prefrontal cortex and amygdala, respectively. No 
significant reduction in caspase-1 activity was seen in the hippocampus (nM/min/µg saline vs. 
YVAD, 0.96 ± 0.15 vs. 0.71 ± 0.07) and hypothalamus (nM/min/µg protein saline vs. YVAD, 
2.11 ± 0.58 vs. 2.02 ± 0.66). YVAD, in comparison to saline, increased time spent in the open 
arms of the elevated zero maze by 65% (% time in open arms saline vs. YVAD, 9.14 ± 1.68 vs. 
14.99 ± 1.71, p=0.023; Figure 2.3B). This increase was not associated with an increase in 
locomotion in the maze (cm moved saline vs. YVAD, 2017.46 ± 204.21 vs. 2022.35 ± 147.71, 
p=0.98).  
 
Caspase-1 and IL1-R1 knockout (KO) mice are resistant to fasting-induced improvements 
in anxiety-like behavior. To further determine if anxiety-like behavior is dependent on the IL-1β 
system caspase-1 and IL1-R1 KO mice were examined with or without fasting. Figure 2.4A 
shows that in the elevated zero maze caspase-1 KO mice have no fasting-induced change in 
anxiety-like behavior, while wild-type mice have a 60% increase in time spent in the open arms 
(% time in open arms fed wildtype 12.63 ± 1.64 vs. fasted wildtype 20.44 ± 3.18 vs. fed caspase-
1 KO 18.72 ± 2.43 vs. fasted caspase-1 KO 14.57 ± 1.23); with a significant treatment-genotype 
interaction (p=0.019)). Figure 2.4B shows that caspase-1 KO mice move less during the task 
than wildtype mice (cm moved fed wildtype 1811.95 ± 180.07 vs. fasted wildtype 175.93 ± 
190.06, vs. fed caspase-1 KO 1353.65 ± 115.96 vs. fasted caspase-1 KO 1470.53 ± 74.79); 
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significant effect of genotype (p=0.001)). Figure 2.4C demonstrates that IL-1R1 KO mice are 
resistant to fasting induced changes in anxiety-like behavior (% time in open arms fed wildtype 
20.93 ± 2.35 vs. fasted wildtype 33.50 ± 5.07 vs. fed IL-1R1 KO 28.54 ± 4.04 vs. fasted IL-1R1 
34.30 ± 3.64); significant main effect of treatment (p=0.032)). Changes in time spent in the open 
arms of the zero maze were independent of changes in locomotor activity within the task (cm 
moved fed wildtype 2866.97 ± 263.28 vs. fasted wildtype 2721.55 ± 209.89 vs. fed IL-1R1 KO 
2514.25 ± 379.15 vs. fasted IL-1R1 KO 2466.17 ± 284.49)). 
 
Discussion 
The starvation response in animals is critical to maintain homeostasis in the event of 
nutrient deprivation. This reaction integrates several metabolic and hormonal signals that 
regulate energy levels (Longo and Mattson, 2014), the quintessential elements of the allostatic 
response. Maintenance of locomotor activity and a reduction in anxiety-like behavior would 
appear advantageous to exploratory behavior required for nutrient acquisition. Likewise, 
improved memory could facilitate both exploration and revisitation. The pro-inflammatory 
cytokine IL-1β directly impacts movement, anxiety and memory (Rothwell and Luheshi, 2000), 
and, in the sickness paradigm, decreases locomotion while promoting anxiety-like behavior and 
memory impairment in aged animals (Savignac et al., 2016, Biesmans et al., 2013, Tarr et al., 
2011). We previously found that a high-fat diet causes behavioral changes similar to those 
triggered by IL-1 administration including anxiety and cognitive impairment (Gainey et al., 
2016, Kaczmarczyk et al., 2013). Importantly, administration of the ATP-sensitive K
+
 (KATP) 
channel blocker glyburide rapidly ameliorates the anxietal and cognitive consequences of a high-
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fat diet (Gainey et al., 2016). Since inflammasome activation can be triggered by a drop in the 
intracellular concentration of K
+
 (Perregaux and Gabel, 1994, Franchi et al., 2007, Katsnelson et 
al., 2015), our previous work suggests that dietary restriction might reduce the activity of 
caspase-1 and that such changes would likely be present in the brain. 
 
Overnutrition can increase caspase-1 activity in the periphery (Mohamed et al., 2014). 
Such increases in caspase-1 appear associated with high-fat diets and the inflammatory 
consequences of obesity outside the CNS (Luo et al., 2014, Solini et al., 2013). While high-fat 
diets have been shown to increase NLRP3 expression in the hippocampus (Sobesky et al., 2016), 
caspase-1 regulation throughout the rest of the brain is currently untied to diet. Figure 2.1 and 
Table 2.2 illustrate that undernutrition reduces caspase-1 activity in the brain in concert with a 
marked reduction in IL-1β gene expression in the prefrontal cortex, amygdala and hypothalamus. 
Surprisingly, Figure 2.1 D shows that, despite changes in IL-1β gene expression, there is no 
change in IL-1β protein concentration. This lack of change in protein levels could be due to the 
sequestering of pro-IL-1β in vesicles (Lopez-Castejon and Brough, 2011). As IL-1β secretion 
can be acutely increased in as little 10 to 20 minutes following ATP stimulation (Brough and 
Rothwell, 2007), it is vital to the inflammatory response of the cell to maintain stable levels of 
IL-1β protein. Several studies have shown this ability to store IL-1β for future release, rather 
than degrading it (Andrei et al., 1999, Rubartelli et al., 1990). While a reduction in the ability of 
the hypothalamus to generate IL-1β makes teleological sense when paired with starvation and the 
anorexigenic properties of IL-1, such outcomes were unexpected in other brain areas. 
Canonically, inflammasome activation and IL-1β gene expression are regulated by two 
independent signals. IL-1β is activated by caspase-1 cleavage of pro-IL-1β, while IL-1β 
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transcription is usually secondary to NFкb as part of TLR4 stimulation (Rodrigues et al., 2008, 
Garcia-Bueno et al., 2016). Caspase-1 activation is generally driven by NLRs (Latz, et al., 2013), 
following sensing of a danger associated molecular pattern (DAMP) or pattern associated 
molecular pattern (PAMP). As a responder to intracellular danger signals, caspase-1 is largely 
constitutively expressed, and is further expressed after induction (Mishra et al., 2010), which 
would explain why we saw little change in expression of the genes comprising the 
inflammasome. However, this is in contrast to our finding in Figure 2.1 A-C, where we saw 
decreased caspase-1 activity, which suggests that suppression of caspase-1 activity may be due to 
factors affecting the assembly of the inflammasome complex, such as the effects of fasting on 
oxidative state (Johnson et al., 2007). Likewise, autophagy directly targets the inflammasome for 
destruction (Shi et al, 2012, Harris et al., 2011, Saitoh et al., 2008) and 24 hours of fasting can 
trigger autophagy in mouse neurons (Alirezaei et al., 2010). Similar to glyburide, the ketone 
body β-hydroxy butyrate inhibits the inflammasome by preventing potassium efflux (Youm et 
al., 2015) and ketone bodies are elevated by fasting in mice (McGarry and Foster, 1980). Thus, 
the ability of fasting to both reduce IL-1β gene expression and caspase-1 activity, while having 
no effect on IL-1β protein, could be a sign of both short, and long-term inhibition of IL-1 
signaling in the brain. 
 
YVAD-biotin labeling in the brain demonstrated that active caspase-1 was primarily 
localized to cells morphologically consistent with neurons in the prefrontal cortex, amygdala and 
hippocampus. In the hypothalamus, cell type was less discernable. While resident immune cells, 
such as microglia, are principally thought to produce and elaborate inflammatory cytokines, 
several studies show that human neurons contain an inflammasome (Ward and Ergul, 2016, 
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Kaushal et al., 2015). In cultured primary cortical neurons, ethanol can induce caspase-1 
activation and HMGB1 release (Wang et al., 2015a). Primary cortical neuron cultures 
demonstrate inflammasome activation mediated by K+ efflux in response to acidosis (Wang et 
al., 2015b). In vivo, an ability of neurons to possess and activate the inflammasome is seen in 
human patients with temporal lobe epilepsy (Tan et al., 2015). Outside the brain, NALP3-
induced caspase-1 activation is observed in neurons of the trigeminal ganglia (Chen et al., 2014). 
What role brain-based caspsae-1 plays in health and disease is still not clear and this is especially 
true for neuronal caspase-1, but endogenous IL-1 is important to certain aspects of anxiety-like 
behaviors, learning (Goshen et al., 2007) and memory (Yirmiya et al., 2002, Avital et al., 2003) 
in the healthy state (Schneider et al., 1998). As example, changes in proteins responsible for IL-1 
production and/or its signaling influence brain function with the best evidence being gleaned 
from studies using IL-1 antagonists (Maes et al., 2012, Neveu and Liege, 2000). Pertinent to our 
findings, undernutrition has been shown to positively impact behavior in that intermittent fasting 
has been shown to improve Barnes maze performance and fear conditioning (Li et al., 2013). In 
contrast, some previous work looking at calorie restriction or intermittent fasting on elevated 
plus maze performance does not demonstrate an impact of these interventions (Yammamoto et 
al., 2009). This is likely related to the acuteness of the fasting paradigm which here resulted in a 
near 23% drop in body weight. Such drastic reductions in body weight may limit the 
translatability of this work. In one study of the starvation response in humans, it was found that 
24 hours of fasting only reduced body weight by 1.9%, and only by 9.5% over ten days 
(Consolazio et al., 1967). Reviews on the topic of calorie restriction, however, (regardless of 
how it is implemented) appears to benefit certain cognitive tasks (Cherif et al., 2016). Thus, the 
model of fasting used here, provides meaningful mechanistic insights into this phenomenon. In 
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turn, recent work by Traba et al. shows a decreases in NLRP3 inflammasome activation in 
primary leukocytes from a 24 hour fast in human (Traba et al., 2015) suggesting a potential 
general applicability of dietary-regulation of caspase-1. Finally, weight reductions in mice are 
tightly correlated to increases in IL-1R2 and IL-1RA in liver and fat, but not in serum (Joesting 
et al., 2014) insinuating that an acute fast impacts IL-1 signaling peripherally and centrally. 
 
As a potent inhibitor of caspase-1, YVAD affects a broad range of biobehaviors. YVAD 
markedly decreases depressive like behaviors in LPS-induced treated mice (Zhang et al., 2014). 
We, and others, find that YVAD can abrogate memory loss induced by hypoxia and aging (Chiu 
et al., 2012, Gemma et al., 2005). Interestingly, YVAD appears to be a potent anxiolytic 
reducing anxiety-like behaviors in the basal state (Figure.2.3). In regards to body weight, food 
intake and locomotor activity, centrally administered YVAD had little effect even though it 
inhibited caspase-1 activity in the prefrontal cortex and amygdala. The inability of YVAD to 
modify food intake or locomotor activity could be due to the absence of caspase-1 inhibition in 
the hypothalamus, as this region is the main regulator of energy homeostasis in the brain 
(Yamanaka et al., 2003). Support for this contention is observed in mouse models of obesity, 
where YVAD attenuates inflammation while failing to impact body weight, fat mass and glucose 
levels (Morrison et al., 2016). 
 
Finally, in mice lacking caspase-1 or IL-1R1, a fasting-dependent reduction in anxiety-
like behaviors was not observed suggesting that caspase-1 and IL-1R1 are critical to anxiolysis in 
fasted mice. Although caspase-1 and IL-1R1 mice were not statistically different from WT mice 
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in regards to anxiety-like behavior in the fed state using 2-way ANOVAs, t-testing demonstrated 
significance for caspase-1 mice. The inability of IL-1R1 knockout to improve anxiety-like 
behavior on its own could be due to several mechanisms. It is possible that expression of other 
IL-1 receptors is altered in these animals, since we have previously shown that fasting can 
increase IL-1R2 expression in the cortex (Joesting et al., 2014). The observation that caspase-1 
KO mice do not show reduced anxiety could be due to compensation in IL-1β processing 
through caspase-1 independent production (Mayer-Barber et al., 2010, Provoost et al., 2011), or 
a redundancy, aka IL-1α. It has been shown that caspase-1 KO mice still secrete IL-1α (Kuida et 
al., 1995). This compensatory effect of IL-1 can be seen in mouse models of ischemic brain 
damage, were animals lacking IL-1β or IL-1α were susceptible to damage, but mice lacking both 
were protected (Boutin et al., 2001). However, this finding genetic deletion of core components 
of the IL-1 signaling pathway do not improve behavior at basal conditions is similar to previous 
work in which IL-1RA overexpressing mice demonstrated impaired spatial memory compared to 
WT controls (Goshen et al., 2007). Taken together, our data suggest that acute fasting can inhibit 
caspase-1 activity in the brain and that this effect is particularly concentrated in neurons of the 
prefrontal cortex, amygdala and hippocampus. Reductions in brain caspase-1 activity reduce 
anxiety and improve memory. These results suggest that the low energy levels induced by fasting 
activate the type 1 allostatic overload response which we demonstrate inhibits casaspe-1 and 
improves behavioral adaptations. Thus, fasting could prove to be a potent intervention to 
improve brain function during stress. 
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CHAPTER 3: HIGH-FAT DIET REFEEDING INCREASES ENERGY LEVELS AND 
ACTIVATES THE TYPE 2 ALLOSTATIC OVERLOAD RESPONSE WHICH 
INCREASES INFLAMMASOME ACTIVATION AND IMPAIRS MEMORY 
Abstract 
Obesity prevalence is increasing year-over-year and so are its neurological comorbidities 
that present along with it. Over consumption of calories is a significant causal factor in the 
development of obesity, and represents a significant form of metabolic stress. Further, the 
hallmark of the type 2 allostatic overload response to stress is the presence of high energy levels, 
a factor that would be expected from overconsumption. To date, one of the most effective 
treatments for obesity is calorie restriction; including new paradigms like alternate day fasting 
and time restricted feeding regimes. Such diets decrease obesity and improve concomitant 
cognitive dysfunction. However, these diets can induce binge eating following the fasting period, 
and it remains unknown whether this type of acute overconsumption can result in type 2 
allostatic overload response, including cognitive sequela. Here, we show that acute refeeding for 
2 hr with high-fat diet (HFD), but not chow or low-fat diet (LFD) reduces novel object 
recognition (NOR) and novel location recognition (NLR) memory by 13% and 14% respectively.  
Additionally, HFD refeeding increases caspase-1 activity in the amygdala by ~100%. Memory 
impairments were negatively correlated with kcal consumption during refeeding, while caspase-1 
activity was positively correlated with kcal consumption. Further, genetic deletion of either 
caspase-1 or IL-1 receptor 1 (IL1R1) eliminated recognition memory impairments due to HFD 
refeeding. Oxidative stress played a causal role in caspase-1 activation and cognitive 
dysfunction, as the antioxidant n-acetylcysteine (NAC; 50 mg/kg) improved NOR and NLR 
performance by 18% and 14% respectively, and reduced caspase-1 in HFD fed animals by 169%. 
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Finally, a free-fatty acid receptor 1 (FFAR1) antagonist, capable of inhibiting palmitic acid 
induced GPCR activity, improved NOR and NLR by 12% and 14% over vehicle treated HFD fed 
mice. However, FFAR1 antagonism did not have any effect on caspase-1 activation. Taken 
together, these data suggest that acute overconsumption during refeeding activates caspase-1 in 
the amygdala which leads to cognitive impairment following type 2 allostatic overload. Further, 




During 2015-2016 the prevalence of obesity in the U.S.A. was thought to be nearly 40% 
in adults and over 18% in children (Hales et al., 2017). While several mechanisms are thought to 
contribute to the current obesity epidemic, the overconsumption of foods, especially high-calorie 
and easily accessible foods, are thought to play a significant role (Cutler et al., 2003). The ability 
of low-calorie diets of varying composition to lower body weight, but not that of exercise or 
other interventions, shows the importance of nutritional energy consumption in obesity 
prevalence (Shai et al., 2008, Das et al., 2007, Loiselle and Barclay, 2017). Additionally, obesity 
often presents with a wide variety of comorbidities, including diabetes (Scheen and Van Gaal, 
2014), cardiovascular disease (Katsareli and Dedoussis, 2014), and neurological complications 
like cognitive impairment (Prickett et al., 2015) and depression (Olvera et al., 2015).   
 
Recently, Inflammation has been found to play a critical role in mediating the connection 
between obesity and its comorbidities, as it is individually associated with the pathophysiology 
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of many chronic diseases (Adler, 2011, Hunter, 2012, Libby, 2007). This connection is 
particularly evident in neurological comorbidities, such as cognitive decline (Miller and Spencer, 
2014, Guillemot-Legris and Muccioli, 2017). Not only can neuroinflammation induce cognitive 
decline, it can also perpetuate obesity, by damaging feeding centers in the hypothalamus 
(Williams, 2012, de Git and Adan, 2015). In extreme cognitive impairment, such as Alzheimer’s 
disease, inflammation due to high-fat diet consumption contributes to disease risk (Walker and 
Harrison, 2015). In one 20 year longitudinal study, those with high interleukin (IL)-6 levels had a 
greater likelihood of cognitive impairment (Wichamann et al., 2014). In elderly populations, 
higher inflammatory markers were associated with lower cognitive ability (Baierle et al., 2015). 
Finally, the NLRP3-caspase-1 containing inflammasome complex, responsible for the maturation 
of IL-1β, has been implicated in these neurodegenerative diseases as well (Guo et al., 2015). 
 
To date, one of the most effective treatments for obesity is caloric restriction (Redman 
and Ravussin et al., 2011). Caloric restriction has also been shown to be effective at treating 
chronic inflammatory conditions (Gonzales et al., 2012) and has potent effects on longevity 
(Willcox and Willcox, 2014, Trepanowski et al., 2011). We have previously shown that fasting 
has the ability to reduce inflammation and improve cognition in mice as well (Towers et al., 
2017). However, as overall caloric restriction can be difficult to achieve in normal human 
populations, new methods to reduce calorie intake have become more prominent, such as 
intermittent fasting (IF; Anton and Leeuwenburgh, 2013). A review of studies in diabetic 
patients showed that IF, as well as alternate day fasting (ADF) are just as effective at 
ameliorating the consequences of diabetes as caloric restriction (Barnosky et al., 2014). A mouse 
study found that alternate day fasting could improve cognitive function and reduce oxidative 
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stress in the brain (Li et al., 2013). However, these alternate-day feeding and other time-
restricted eating patterns induce binging behavior in animal models, where time-restricted mice 
consume their daily allotment of food within two hours (Acosta-Rodriguez et al., 2017), which 
would induce high energy levels temporarily.  
 
Although it is well known that prolonged high energy levels negatively affect cognition 
(Mattson, 2010), how binging behavior observed during by restricted feeding regimes might 
affect cognition is unknown. In fact, many studies avoid this complication altogether by 
performing behavioral testing during feeding periods (Singh et al., 2012, Brandhorst et al., 
2016). To determine how binging following fasting in these calorie restriction paradigms affects 
cognition the present study fasted mice for 24 hours and then refed them with normal chow, low-
fat diet (LFD), or high-fat diet (HFD) for 2 hr. Mice were then examined on the novel object 
recognition and novel location recognition tasks to determine cognitive ability. We also examine 
how inflammatory mechanisms, specifically activation of the IL-1 arm of the neuroimmune 
system by inflammasome activation, can contribute to cognitive changes following refeeding 
binges. Thus, this study highlights to role of a single, hypercaloric, meal on the pathogenesis of 
cognitive disorders that are comorbid with obesity. Additionally, this study highlights the role of 
high energy levels in activating the inflammasome and inducing behavioral dysfunction in a 







Materials-All reagents were purchased from Sigma-Aldrich (St Louis, MO) unless 
otherwise stated.  
 
Animals- Animal use was performed according to protocols approved by the Institutional 
Animal Care and Use Committee at the University of Illinois. Wild-type C57BL/6J (WT), 
Caspase-1 (Casp-1) knockout (KO), interleukin (IL)-1 Receptor 1 (IL1R1) KO mice were 
originally purchased from The Jackson Laboratory (Bar Harbor, ME) and bred in-house.  Mice 
were provided food and water ad libitum (ad lib) in standard shoebox cages unless otherwise 
stated.  Animals were group housed (up to 8 per cage), then moved to individual housing the day 
prior to the beginning of experimentation unless noted otherwise. Housing temperature (72 °F) 
and humidity (45–55%) were controlled, and a 12/12h reversed dark-light cycle (2200–1000 h) 
was maintained. Animal behavior was video recorded using a Sony HDR-XR500V Night Shot 
capable video camera (Tokyo, Japan). Mice used were between 9 and 15 weeks of age. All 
behavior testing was completed under red lights in the dark cycle unless otherwise indicated.  
422 mice were used in total. 
 
Diet treatment, food intake, and body weight- 2 days prior to dietary treatment, mice were 
individually housed. Mice were fasted for 24 hrs by placing mice in a new cage without food but 
with ad lib access to water. For the refeeding treatment, fasted mice were provided ad lib access 
to either normal chow (Chow; Diet 7013, Envigo, Madison, WI), low-fat diet (LFD; D12450B, 
Research diets, New Brunswick, NJ), or high-fat diet (HFD; D12492, Research Diets, New 
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Brunswick, NJ). For behavioral experiments, mice underwent the training phase of the NOR and 
NLR task prior to receiving access to refeeding diets, and then had access to refeeding diets for 2 
hr. For biochemical experiments mice were immediately provided food for 2 hr following 
fasting.  Food weight was measured from petri dishes placed inside mouse cages. Mouse weight 
was recorded at the time points indicated using an Ohaus Adventurer Pro digital scale 
(Parsippany, NJ). 
 
Injectables- Biotin-YVAD-CMK (YVAD) was obtained from AnaSpec (Fremont, CA). 
N-Acetylcysteine (NAC) was obtained from sigma Aldrich (St. Louis, MO). NAC was injected 
IP at a dose of 50 mg/kg. DC260126, the free fatty acid receptor (FFAR) 1 antagonist, was 
obtained from Tocris biosciences (Minneapolis, MN). DC260126 was solubilized into DMSO, 
and then diluted into saline to achieve a 4% DMSO final solution. DC260126 was injected IP at 
a dose of 10 mg/kg, with a 4% DMSO solution serving as the vehicle control.  
 
Novel Object Recognition- Novel object recognition was examined as previously 
described (Towers et al., 2017, York et al. 2012).  Mice were placed in a rat cage-sized arena (26 
cm × 48 cm × 21 cm) containing two identical objects on opposite ends of the arena (training). 
After 30 minutes, objects were removed and cleaned and sanitized with ethanol. Mice were 
returned to home cages and given access to treatment diets. Testing was initiated 2 hrs following 
the end of training.  During testing, two objects were replaced in the cage, one seen during 
training (familiar object) and one unfamiliar object (novel object). Object investigation was 
video recorded for 5 min and evaluated by a blinded observer. Novel and familiar object % 
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investigation was calculated by dividing the time spent examining each object by the total object 
investigation time. Results are expressed as % Novel object investigation. 
 
Novel Location Recognition- Novel object location recognition was assessed in a method 
adapted from previously described novel object recognition test (Towers et al., 2017, York et al. 
2012). Briefly, mice were placed in a large rat-sized cage (26 cm x 48 cm x 21 cm) arena with 
spatial cues marked on three sides.  During the training phase, two identical objects were 
presented to the animal on one side of the arena.  After 30 minutes of training, the objects were 
removed from the testing arena and sanitized with ethanol. Mice were returned to home cages 
and given access to treatment diets.  Testing was initiated 2 hrs following the end of the training 
phase.  During testing, one of the objects was placed in the same location as during training 
(familiar location), and the other object was placed on the opposite end of the arena (novel 
location). Investigation was video recorded for 5 min and evaluated by a blinded observer. Novel 
and familiar location % investigation was calculated by dividing the time spent examining each 
location by the total investigation time to determine the degree to which the mouse investigated 
the novel location. Results are expressed as % Novel location investigation. 
 
Locomotor activity- Spontaneous locomotor activity was measured as we have previously 
described (York et al., 2012). Mice were video recorded in modified home cages for 5 min using 
a Sony Night Shot capable video camera (Minato-ku, Tokyo) Distance moved was quantified 




Activated caspase-1 labeling- Following fasting, mice were deeply anesthetized with 
ketamine/xylazine (80mg/kg/ 12mg/kg) then were injected with 100 ng of biotin-YVAD-CMK 
ICV using a microinjection unit attached to a Kopf sterotaxic. 2 Hours following biotin-YVAD-
CMK injection mice were euthanized using CO2 and perfused with ice cold PBS followed by 
4% paraformaldehyde. Brains were sectioned at 1.5 and 3.5 mm from the interaural coronally 
using a Mouse Brain Slicer (Zivic Insttruments, Pittsburgh, PA). Slices were fixed in 4% 
paraformaldehyde for 24 hours then paraffin embedded. 5μm slices from the two sections were 
blocked with hydrogen peroxide (Peroxidazed (PX968)) and labeled with SS HRP Label (4+ 
Strep HRP Label (HP604)), stained with liquid 3.3’-diaminobenzidine (DAB) chromogen (IP 
FLX DAB (IPK5010)), counterstained with hematoxylin (Cat Hematoxylin (CATHE)) and 
mounted and coverslipped with the BioCare IntelliPATH. The entire slide was imaged at 40x 
with a NanoZoomer 2.0-HT (Hamamatsu, Bridgewater, NJ). Area of staining was measured 
using ImageJ (National Institute of Health). Due to variation in staining between similar 
experiments performed on different days results are expressed as % control. 
 
Statistics - Data are expressed as mean ± SEM. Analysis was conducted using Sigma Plot 
11.2 (Systat Software, Chicago, IL).  To test for statistical differences, one-way and two-way 
ANOVAs were used.  Pearson product moment correlation was used to determine correlation 
coefficients. Data were transformed where necessary to attain normality or equal variance. Post-






HFD refeeding increases calorie intake and impairs memory. Mice were examined 
following 2 hr of diet refeeding. Table 3.1 shows that mice refed with chow, low-fat diet (LFD), 
or high-fat diet (HFD) all gained a similar amount of weight and present at a similar body weight 
following 2 hr of refeeding. However, mice refed with either chow or HFD consume 50% more 
food weight than the LFD group during the 2 hr period. When converted into kcal, the HFD mice 
consume 230% more calories than either the LFD or chow fed groups during the refeeding 
period. Despite these differences in food intake, no dietary treatment had significantly different 
total locomotor activity.  
 
Refed mice were examined on both recognition and spatial memory tasks. Fig. 3.1A 
shows that HFD-refed mice had a 13% decrease in novel object recognition (NOR) performance 
compared to chow and LFD groups (% novel object investigation, Chow vs. LFD vs. HFD, 64.99 
± 5.58 vs. 67.05 ± 1.04 vs. 51.99 ± 3.76, p=0.010). This difference in NOR performance was 
negatively correlated to kcal intake during refeeding (r=-0.542, p=0.007) (Fig. 3.1B). Fig. 3.1C 
shows that HFD-refed mice also exhibit a 14% reduction in spatial memory in the novel object 
location (NOL) task compared to chow and LFD groups (% novel location investigation, Chow 
vs. LFD vs. HFD, 64.01 ± 3.83 vs. 58.68 ± 4.33 vs. 50.72 ± 2.44, p=0.035), and a significant 





HFD refeeding activates caspase-1 in the amygdala of mice which is correlated with 
calorie intake. Recently, HFD feeding has been shown to prime the protein complex known as 
the inflammasome, which is responsible for the maturation of IL-1β (Reynolds et al., 2012). To 
determine if HFD refeeding is capable of activating the inflammasome we examined caspase-1 
activity in the amygdala following refeeding. Fig. 3.2A shows that HFD refeeding increased 
caspase-1 activity by over 100% in the amygdala (% Control caspase-1 activity, Chow vs. LFD 
vs. HFD, 100 ± 13.79 vs. 81.99 ± 15.15 vs. 205.88 ± 26.04, p<0.001). Unlike memory 
performance, caspase-1 activation was positively correlated with kcal intake during refeeding 
(r=0.462, p=0.00454; Fig 3.2C).  
 
Mice that lack caspase-1 or IL1R1 exhibit no HFD-induced memory impairment. Fig. 
3.3A shows that caspase-1 KO mice fed HFD have a 22% increase in novel object investigation 
compared to wild-type (WT) animals fed HFD (% novel object investigation, WT Chow vs. 
Caspase-1 KO Chow vs. WT LFD vs. Caspase-1 KO LFD vs. WT HFD vs. Caspase-1 KO HFD, 
65.76 ± 2.76 vs. 62.58 ± 5.63 vs. 71.71 ± 2.58 vs. 70.39 ± 2.17 vs. 39.41 ± 4.36 vs. 63.01 ± 6.33, 
significant genotype x diet interaction, p=0.008). To ensure the involvement of IL-1β in our 
pathway leading to memory impairment we performed the same experiment in IL1R1 KO mice. 
Fig. 3.3B shows that IL1R1 KO mice refed with HFD exhibit an 11% increase in NOR 
investigation compared to HFD fed WT mice (% novel object investigation, WT Chow vs. 
IL1R1 KO Chow vs. WT LFD vs. IL1R1 KO LFD vs. WT HFD vs. IL1R1 KO HFD, 56.54 ± 
4.11 vs. 54.90 ± 4.54 vs. 67.63 ± 3.06 vs. 62.37 ± 2.68 vs. 46.23 ± 5.03 vs. 57.17 ± 2.84, 
significant effect of diet, p=0.003).  
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The antioxidant NAC ameliorates memory impairment and caspase-1 activation caused 
by HFD refeeding. Oxidative stress is one of the most well-known activators of the 
inflammasome (Zhong et al., 2013, Salminen et al., 2012), and high energy levels can readily 
increase oxidative stress (Yuzefovych et al., 2013, Liu et al., 2015). To determine if oxidative 
stress due to the increased calorie consumption from HFD refeeding was responsible for caspase-
1 activation and memory impairment mice were administered the antioxidant n-acetylcysteine 
(NAC; 50 mg/kg) or saline (Sal) vehicle control prior to refeeding. Fig. 3.4A shows that NAC 
improves NOR performance by 18% in HFD refed mice compared to saline treated HFD refed 
mice (% Novel object investigation, Sal Chow vs. NAC Chow vs. Sal LFD vs. NAC LFD vs. Sal 
HFD vs. NAC HFD, 64.95 ± 4.14 vs. 64.19 ± 2.59 vs. 62.60 ± 2.68 vs. 65.82 ± 1.82 vs. 45.79 ± 
3.64 vs. 63.99 ± 3.54, significant treatment x diet interaction, p=0.011). NAC also improves 
NOL performance in HFD refed mice by 14% over saline treated HFD fed mice (% Novel object 
investigation, Saline chow vs. NAC chow vs. Saline LFD vs. NAC LFD vs. Saline HFD vs. 
NAC HFD, 64.68 ± 3.01 vs. 61.21 ± 4.76 vs. 66.36 ± 3.85 vs. 63.08 ± 4.98 vs. 45.45 ± 6.48 vs. 
59.19 ± 2.83, significant effect of diet treatment, p=0.017; Fig. 3.4B). Additionally, Fig. 3.4C 
shows that NAC reduced caspase-1 activity in HFD refed mice by 169% in the amygdala (% 
Control caspase-1 activity, Sal Chow vs. NAC Chow vs. Sal LFD vs. NAC LFD vs. Sal HFD vs. 
NAC HFD, 100 ± 10.33 vs. 156.93 ± 40.83 vs. 138.19 ± 11.9 vs. 181.20 ± 30.16 vs. 356.96 ± 
79.32 vs. 187.31 ± 69.47, significant main effect of diet; p=0.034). 
 
Pharmacologic inhibition of the palmitic acid receptor FFAR1 improves memory via a 
mechanism independent of caspase-1. The saturated fatty acid palmitate has been identified as an 
activator of the inflammasome through its ability to generate reactive oxygen species and 
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oxidative stress (Wen et al., 2011). To determine if palmitic acid signaling through its receptor, 
FFAR1, was involved in our mechanistic pathway mice were administered DC260126 (FFAR 
antag; 10 mg/kg) immediately prior to refeeding.  Fig. 3.5A shows that FFAR1 antagonism 
improved NOR performance by 12% in HFD fed mice (% Novel object investigation, DMSO 
chow vs. FFAR Antag chow vs. DMSO LFD vs. FFAR Antag LFD vs. DMSO HFD vs. FFAR 
Antag HFD, 61.46 ± 4.85 vs. 68.62 ± 3.66 vs. 72.35 ± 2.74 vs. 63.11 ± 2.22 vs. 51.51 ± 6.37 vs. 
63.17 ± 3.46, significant drug treatment x diet interaction, p=0.027). Additionally, Fig. 3.5B 
shows that FFAR antagonism also improves NOL performance by 14% in HFD refed mice (% 
Novel object investigation, DMSO chow vs. FFAR Antag chow vs. DMSO LFD vs. FFAR 
Antag LFD vs. DMSO HFD vs. FFAR Antag HFD, 62.46 ± 3.09 vs. 58.83 ± 1.97 vs. 60.78 ± 
3.17 vs. 60.03 ± 2.49 vs. 50.62 ± 4.11 vs. 64.54 ± 1.85, significant drug treatment x diet 
interaction, p=0.009). Despite improvements to memory following FFAR1 antagonism, FFAR1 
antagonism decreased caspase-1 activity by 45% in the amygdala, which was not significantly 
different compared to HFD refed mice administered vehicle control (% Control caspase-1 
activity, DMSO Chow vs. FFAR antag Chow vs. DMSO LFD vs. FFAR antag LFD vs. DMSO 
HFD vs. FFAR antag HFD, 100 ± 19.06 vs. 121.15 ± 15.37 vs. 123.96 ± 18.08 vs. 109.44 ± 
18.31 vs. 224.07 ± 45.55 vs. 179.91 ± 49.69, significant main effect of diet, p=0.011; Fig. 3.5C).  
 
Discussion 
Refeeding has presented a wide variety of complications in a variety of situations, 
especially in extreme cases such as anorexia nervosa (O’Connor and Nicholls, 2013, Hofer et al., 
2014). Part of the reason for such complications is the intense and immediate physiologic 
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changes that occur after refeeding. In volunteers fasted for 12 or 24 hrs refeeding can rapidly 
increase liver glycogen in as little as 2 hr (Awad et al., 2010), and modifies the entire metabolic 
environment in muscle tissue (Pilegaard et al., 2003). Within the brain, 1 hr of refeeding is 
enough to activate neural circuits in the brainstem and hypothalamus (Wu et al., 2014). The same 
study showed that these neural effects coincided with changes in the circulating energy 
regulators insulin and leptin, as well as energy substrates like glucose and non-esterified fatty 
acids (NEFAs).  Refeeding has also been shown to cause an inflammatory response in the liver, 
increasing the expression of pro-inflammatory cytokines like TNF-α and IL-1β (Lee et al., 2013). 
The composition of the diet is also an important consideration during refeeding, as a recent study 
showed that diets containing α-cornstarch or glucose increased inflammatory gene expression 
more than diets containing fructose (Oarada et al., 2015). Including anti-inflammatory agents, 
such as fish oil, in the diets can also modify the inflammatory response to refeeding (de Castro et 
al., 2015). The current study expands upon these results by showing that 2 hr of refeeding with a 
high-fat diet (HFD), but not chow or low-fat diet (LFD) activates the pro-inflammatory 
inflammasome complex within the amygdala (Fig. 3.2). Additionally, table 3.1 shows that HFD 
refeeding induces a significant increase in kcal intake over chow and LFD refed mice. In fact, 
activation of caspase-1 was positively correlated with kcal intake during refeeding (Fig . 3.2C), 
suggesting that it is energy level and not diet composition that plays an important role in the 
inflammatory response during refeeding. 
 
Previous results also suggest that refeeding and overconsumption act as a potent 
metabolic stressor. Stress-induced increases in catecholamines were shown to be essential to 
glycogen storage in brown adipose tissue following refeeding (Carmean et al., 2013). 
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Additionally, administration of norepinephrine can recapitulate several of the effects of refeeding 
in rats (Rothwell et al., 1983). In humans, refeeding increases catecholamine excretion through 
urine, suggesting a strong effect (Koppeschaar et al., 1985). This stress effect is particularly 
apparent in the amygdala, as fasting/refeeding stress caused the greatest increase in amygdala 
activity compared to other stressors like acute social defeat or LPS injection. These results 
provide suggest that it is the amygdala’s particular role in regulating stress and allostatic 
overload that resulted in the marked increase in caspase-1 activity in this region. Indeed, our 
results also support this contention, as amygdala caspase-1 was significantly increased due to 
HFD refeeding, which conforms to the hypothesis that amygdala-based caspase-1 activation is a 
component of the type 2 allostatic overload response (Fig. 3.2A). 
 
In addition to mediating the stress response, the amygdala plays an important role in 
memory processes throughout the brain (Hermans et al., 2014, Kilpatrick and Cahill, 2003). Fig. 
3.1 shows that HFD refeeding causes significant negative effects to both recognition (Fig. 3.1A) 
and location memory (Fig. 3.1C). A variety of mechanisms have been identified that could be 
mediating this response to HFD refeeding. The neurotrophic agent, brain-derived neurotrophic 
factor (BDNF) is markedly reduce following HFD feeding (Noble et al., 2014), and decreases in 
BDNF from HFD feeding have been linked to decreased synaptic plasticity (Woo et al., 2013). 
These changes are linked to behavioral abnormalities consistent with our memory impairment. 
HFD feeding-induced cognitive dysfunction could also be due to reduced neurogenesis (Boitard 
et al., 2012), and increased inflammation has been linked to reduced neurogenesis. However, 
Fig. 3.3A shows that caspase-1 is mechanistically required for memory impairment. 
Additionally, IL-1β, the main substrate caspase-1 acts on, is also well-known to be able to impair 
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memory (Hein et al., 2010, Chiu et al., 2012). We also demonstrate the importance of IL-1β in 
HFD refeeding-induced memory impairment, as genetic knockout of the IL-1 receptor 1 (IL1R1) 
eliminated recognition memory deficits (Fig. 3.3B). These results suggest that inflammasome 
activation and IL-1β secretion are mechanistically linked to the memory impairment we 
observed. Further, hypoxic stress has been shown to impair memory in a similar caspase-1 
dependent manner as well (Chiu et al., 2012). 
 
However, the inflammasome itself requires activation via a danger signal (Latz et al., 
2013). Of the most common danger signals capable of activating the inflammasome, several 
relate to cellular energy dynamics, including cellular reactive oxygen species (ROS) and 
oxidative stress (Abderrazak et al., 2015). Further, HFD feeding and high calorie loads from fatty 
acids can induce oxidative stress, which can lead to cognitive dysfunction (Patki et al., 2013). 
We have previously shown HFD-induced oxidative stress and memory impairment in as little as 
1 week (Gainey et al., 2016). Fig 3.4A and B show that the cellular antioxidant n-acetylcysteine 
(NAC), ameliorated recognition and location memory impairment in HFD refed mice. This 
suggests that ROS play a mechanistic role in memory impairment during HFD refeeding induced 
memory impairment. Other studies have shown the ability of refeeding to increase peroxidation 
products, another sign of increased oxidative stress (Nassar et al., 2014), and suggest that the 
beneficial effects of NAC in our experiments are in reducing this oxidative stress. Intriguingly, 
NAC also reduces caspase-1 activation in the amygdala (Fig. 3.4C and D). This result 
corroborates ex vivo studies that have shown oxidative stress can activate the inflammasome, by 
demonstrating the ability of an antioxidant to reduce caspase-1 activity within the brain (Zhang 
et al., 2017). Energy levels play a critical role in mediating the TXNIP-oxidative stress-
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inflammasome activation, as glucose levels dose-dependently increase expression of TXNIP, 
NLRP3, and IL-1β which regulate inflammasome activation (Feng et al., 2016). These results 
suggest that HFD refeeding overconsumption induces oxidative stress and ROS generation 
which leads to caspase-1 activation and IL-1β-induced memory impairment. These results also 
suggest that this type of high energy metabolic stress activates the type 2 allostatic overload 
response, which results in memory impairment. 
 
Caspase-1 activation and memory impairment was only observed in HFD refed mice, but 
not LFD refed mice, suggesting that glucose intake is not linked to the observed oxidative stress 
and caspase-1 activation we observe. HFDs contain a significant fraction of saturated fatty acids, 
particularly palmitic acid. We have previously shown that palmitic acid alone is enough to cause 
anxiety-like behavior (Moon et al., 2014). Others have shown that HFDs high in saturated fatty 
acids can cause inflammasome activation (Mohamed et al., 2014, Finucane et al., 2015). 
However, the same study showed that replacing the saturated fatty acid with unsaturated fatty 
acids eliminates IL-1β activation. Fig. 3.5A and B show that inhibiting the receptor for palmitic 
acid, free-fatty acid receptor 1 (FFAR1) eliminates memory impairment. These results would 
suggest that FFAR1 stimulation negatively regulates memory during refeeding. However, at least 
one study has shown that FFAR1 agonism improved memory in an Alzheimer’s disease model 
(Khan et al., 2016). This effect was attributed to polyunsaturated fatty acids, which may be a 
substrate for normal FFAR1 activation in the brain (Yamashima, 2008), and could explain the 
differences in results. Whether saturated fatty acids induce a different FFAR1 response is 
unknown, but our results suggest that inhibition of FFAR1 during elevated saturated fatty acid 
consumption produces a beneficial effect on memory. Despite these changes in memory 
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impairment, FFAR1 antagonism produced only a slight trend to decrease caspase-1 activity 
following HFD refeeding (Fig. 3.5C and D). These results could suggest that palmitic acid acts 
via a receptor independent mechanism to activate the inflammasome. Indeed, previous research 
has suggested that the toll-like receptors (TLRs) are responsible for palmitic acid induced 
inflammasome activation (Snodgrass et al., 2013). Another study showed that TLR4, 
specifically, mediates inflammasome activation due to palmitic acid stimulation (Reynolds et al., 
2012). It is also possible that palmitic acid is activating IL-1β via non-canonical pathways, as 
saturated fatty acids can activate caspase-4/5 and trigger IL-1β via this caspase-1 independent 
pathway (Pillon et al., 2016).  
 
Taken together, our results suggest that excessive calorie consumption during refeeding 
induces memory impairments through an oxidative stress-inflammasome mediated pathway. This 
work highlights how just 2 hr of overnutrition can cause cognitive dysfunction and inflammation 
within the amygdala. Further, these results suggest that the oxidative stress from high-energy 
levels are likely responsible for obesity associated neurological dysfunction. These data also 
highly suggest that caspase-1 activation in the amygdala is a critical mediator of behavioral 
response to the type 2 allostatic overload response. In a recently completed clinical trial known 
as CANTOS, an IL-1β antibody significantly reduced cardiovascular outcomes (Ridker et al., 
2017). Our results here suggest a similar therapy should prove effective for obesity related 
neurological disease and other diseases where a type 2 allostatic overload response is implicated. 
Finally, these results have important implications for the implementation of intermittent fasting 
regimes in the treatment of obesity as they can induce similar fast-feast eating patterns. Our 
results suggest that refeeding during such diets should be performed with moderate sized meals, 
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CHAPTER 4: PSYCHOLOGICAL STRESS ACTIVATES THE TYPE 2 ALLOSTATIC 
OVERLOAD RESPONSE VIA A MECHANISM INVOLVING THE ATP METABOLITE 
ADENOSINE TO ACTIVATE CASPASE-1 AND CAUSE MEMORY IMPAIRMENT 
Abstract 
Acute stressors can induce fear and physiologic responses that prepare the body to protect 
from danger. Recently, the allostatic model of stress has been proposed as a framework for 
understanding these responses. A key component of this response is immune system readiness. 
In particular, inflammasome activation appears critical to linking psychological and/or emotional 
stress to the immune system. Here, we show that a novel combination of mouse handling 
procedures impairs novel object recognition (NOR) and activates caspase-1 in the amygdala. 
This handling-stress model combined weighing, scuffing or sham abdominal injection once per 
hr. One round of weigh/scruff/needle-stick had no impact on NOR, but two rounds inhibited this 
learning while not impacting location memory or anxiety-like behaviors. Caspase-1 knockout 
(KO), IL-1 receptor 1 (IL-1R1) KO and IL-1 receptor antagonist (IL-RA)-administered mice 
were resistant to handling stress-induced loss of NOR. In addition, examination of the brain 
showed that handling stress increased caspase-1 activity 85% in the amygdala without impacting 
hippocampal caspase-1 activity. To delineate danger signals relevant to handling stress and 
energy homeostasis, caffeine-administered and adenosine 2A (A2A) receptor KO mice were 
tested and found resistant to memory loss and caspase-1 activation. Finally, mice treated with the 
β-adrenergic receptor antagonist, propranolol, were resistant to handling stress-induced loss of 
NOR and caspase-1 activation. Taken together, these results indicate that stress-induced loss of 
object memory is reliant on a pathway requiring A2A receptor-dependent activation of caspase-1 
in the amygdala that appears reliant on β-adrenergic receptor functionality. Additionally, the role 
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of adenosine suggests that metabolism of the energy substrate ATP plays an important role in 
this process, as would be suggested by the allostatic model of stress. 
 
Introduction 
Acute stressors and heightened states of arousal lead to impairments in certain memory 
tasks in humans (Tollenaar et al., 2008, Smeets et al., 2008). Naturally occurring life stress 
events are also associated with memory deficits (Shields et al., 2017), and the effects of stress on 
memory become more pronounced throughout the lifespan (Hidalgo et al., 2014). Stress affects 
the incidence of mood disorders (Hope and Henderson, 2014) and Alzheimer’s disease 
(Machado et al., 2014), suggesting that the brain is exquisitely sensitive to stress-related 
modifications. In animal models, acute stress impairs recognition memory in the novel object 
task (Nelissen et al., 2018). In the hippocampus, acute stress induces LTD, which is directly tied 
to memory deficits (Wong et al., 2007). Immunological mediators appear to be a mechanism by 
which stress exerts its impact (Maydych et al., 2017). Stress increases circulating levels of pro-
inflammatory cytokines including TNFα, IL-6 and IL-1β (Glovatchcka et al., 2012), and the IL-
1β response in the brain appears to influence the phenotypic expression of stress (Goshen and 
Yirmiya, 2009). 
 
Critical to central nervous system (CNS) generation of IL-1β is the activation of the IL-
1β maturing enzyme caspase-1 (Martinon et al., 2002). Caspase-1 resides intracellularly in a pro 
form that auto-activates with inflammasome assembly (Latz et al., 2013). Interestingly, a variety 
of brain-specific cells contain functional inflammasomes that activate caspase-1 including 
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microglia, astrocytes and neurons (Fann et al., 2018, Gustin et al., 2015, Abdul-Muneer et al., 
2017). Stress, especially metabolic stress, influences inflammasome components and activity. In 
animal models of aging, mitochondrial dysfunction and oxidative stress combine to activate 
inflammasomes (Salminen et al., 2012). In contrast, acute fasting decreases caspase-1 activity, as 
we have shown in neurons of the prefrontal cortex and amygdala (Towers et al., 2017). Since K+ 
influx is a potent initiator of inflammasome assembly (Latz et al., 2013), processes that trigger 
the opening of ion channels allow for a wide range of bioactives and ligand/receptor pathways 
tied to K+ channels to be potential activators of caspase-1. Hence, acute events characterized by 
physiologic and/or emotional stress can potentially engage the innate immune system vis-a-vis 
cells rich in K+ channel subtypes like endothelial cells (Aziz et al., 2018) and neurons (Misonou, 
2018). 
 
Adenosine is an inhibitory neurotransmitter and CNS depressant (Chiu and Freund, 2015) 
that activates caspase-1 in the brain (Chiu et al., 2014). Furthermore, stress influences adenosine 
metabolism and receptor systems reliant on adenosine as a ligand (Crema et al., 2013). In 
zebrafish, chronic unpredictable stress increases the activity of extracellular membrane-bound 
enzymes that metabolize ATP to adenosine (Zimmerman et al., 2016) while acute restraint stress 
causes anxiety-like behaviors in that increases gene expression of adenosine receptors (Piato et 
al., 2011). The involvement of the energy substrate ATP in these processes suggests that 
psychological stress everts a type II allostatic overload response. In mice, acute hypoxia 
enhances caspase-1 activation and decreases memory formation. Since catecholamines increase 
adenosine levels (Latini and Pedata, 2001, Trotta et al., 2015) (likely due to extracellular 
degradation of cAMP (Jackson et al., 2007, Jackson. 2011) and/or ATP (Samiul Alam et al., 
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2015, Sitkovsky et al., 2004)), the adrenergic response to acute stress appears to be a conduit 
through which stress could activate the neuroimmune system and perturb learning. Here we 
examine acute stress-induced memory impairment and determine its reliance on pathways 
requiring A2A receptor-dependent activation of caspase-1. 
 
Methods 
Materials- All reagents were purchased from Sigma-Aldrich (St Louis, MO) unless 
otherwise stated.  
 
Animals - Animal use was performed according to protocols approved by the Institutional 
Animal Care and Use Committee at the University of Illinois. Wild-type C57BL/6J (WT), 
Caspase-1 (Casp-1 KO) knockout (KO), interleukin (IL)-1 Receptor 1 (IL1R1) KO , BALB/c, 
and Adenosine A2A receptor KO (A2A KO) mice were originally purchased from The Jackson 
Laboratory (Bar Harbor, ME) and bred in-house.  Mice were provided food and water ad libitum 
in standard shoebox cages unless otherwise stated.  Animals were group housed (up to 8 per 
cage), then moved to individual housing the day prior to testing unless noted otherwise. Housing 
temperature (72 °F) and humidity (45–55%) were controlled, and a 12/12h reversed dark-light 
cycle (2100–900 h) was maintained. Animal behavior was video recorded using a Sony HDR-
XR500V Night Shot capable video camera (Tokyo, Japan). Mice used were between 9 and 15 
weeks of age. All behavior testing was completed under red lights in the dark cycle unless 
otherwise indicated.  492 mice were used in total. 
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Stress handling- Stress exposure was performed utilizing common experimental 
procedures performed chronically. Briefly, beginning at the start of the dark cycle mice were 
exposed to one of the following stressors once per hr in the listed order: weighing, scruffing, and 
IP needle prick. For experiments where stress was performed for 3 hr total, each of the 
experimental procedures was performed one time. For stress experiments lasting 6 hrs, the 
stressors were performed twice in identical order. Additionally, stressed animal were housed in a 
room with white lights on during the procedure. During stress exposure, control animals were 
housed and unhandled in separate rooms in total darkness. All behavioral and biochemical 
experiments were begun 1 hr after administration of the final stressor. 
 
Normal handling- As with stress handling, 24 hrs prior to experimentation mice were 
single housed. Normal handling was performed identically to stress handling except mice were 
held in the experimenters open hand for a 1 min as opposed to being weighed, scruffed or needle 
stuck Likewise, normal handling was performed under white lights for a 3 hr or 6 hr duration. In 
an adjacent animal behavior suite, control animals were housed similarly to handled animals. All 
behavioral and biochemical experiments began 1 hr after administration of the final handling. 
 
Injectables- Kineret (anakira) was obtained from Amgen (Thousand Oaks, CA). Kineret 
was injected intraperitoneally (IP) at a dose of 1.4 mg/kg. Ac-YVAD-bitotin (YVAD) was 
obtained from AnaSpec (Fremont, CA). Mifepristone was obtained from sigma Aldrich (St. 
Louis, MO) and was dissolved into DMSO, the further dissolved into saline. Mifepristone was 
injected IP at a dose of 25 mg/kg in a 5% DMSO solution, which was used as a control for all 
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mifepristone experiments. Propranolol hydrochloride was obtained from sigma Aldrich (ST. 
Louis, MO). Propranolol was injected IP at a dose of 7 mg/kg. Caffeine was obtained from sigma 
Aldrich (St. Louis, MO). Caffeine was injected IP at a dose of 100 mg/kg. 8-Cyclopentyl-1,3-
dimethylxanthine (CPX) was obtained from Sigma Aldrich (St. Louis, MO). CPX dissolved into 
DMSO then further dissolved into saline and was injected IP at a dose of 5 mg/kg in a 2% 
DMSO solution3,7-Dimethyl-1-propargylxanthine (DMPX) was obtained from Sigma Aldrich 
(St. Louis, MO).  DMPX was dissolved into DMSO then further dissolved into saline yielding at 
final 2% DMSO solution which was injected at a dose of 5 mg/kg. For all DMPX and CPX 
experiments a 2% DMSO solution was used as the vehicle control.  
 
Fasting- As we have described (Towers et al, 2017), 2 days prior to fasting, mice were 
individually housed. Fasting was initiated by placing mice in a new cage without food but with 
ad libitum water. Mice were fasted for 24 h beginning 6 hr after the start of the dark cycle so 
fasting would conclude simultaneously with stress exposure. Fed mice were treated identically to 
fasted mice but were provided ad libitum access to food (fed mice). 
 
Novel Object Recognition- Novel object recognition was examined as previously 
described (Towers et al., 2017, York et al. 2012).  Mice were placed in a rat cage-sized arena (26 
cm × 48 cm × 21 cm) containing two identical objects on opposite ends of the arena (training). 
After 30 minutes, all objects  and mice were removed and objects were cleaned and sanitized 
with ethanol.  Testing was initiated 2 hrs following the end of training.  During testing, two 
objects were replaced in the cage, one seen during training (familiar object) and one unfamiliar 
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object (novel object). Object investigation was video recorded for 5 min and evaluated by a 
blinded observer. Novel and familiar object % investigation was calculated by dividing the time 
spent examining each object by the total object investigation time. Results are expressed as % 
Novel object investigation. 
 
Novel Location Recognition- Novel object location recognition was assessed in a method 
adapted from previously described novel object recognition test (Towers et al., 2017, York et al. 
2012). Briefly, mice were placed in a large rat-sized cage (26 cm x 48 cm x 21 cm) arena with 
spatial cues marked on three sides.  During the training phase, two identical objects were 
presented to the animal on one side of the arena.  After 30 minutes of training, the objects and 
animals were removed from the testing arena and objects were sanitized with ethanol.  Testing 
was initiated 2 hrs following the end of the training phase.  During testing, one of the objects was 
placed in the same location as during training (familiar location), and the other object was placed 
on the opposite end of the arena (novel location). Investigation was video recorded for 5 min and 
evaluated by a blinded observer. Novel and familiar location % investigation was calculated by 
dividing the time spent examining each location by the total investigation time to determine the 
degree to which the mouse investigated the novel location. Results are expressed as % Novel 
location investigation. 
 
Elevated Zero Maze- As previously described (Towers et al., 2017, Kaczmarczyk et al. 
2013), a zero maze consisting of two walled arms (14 cm) and 2 open arms was under white light 
illumination. Mice were placed in one of the high walled arms to begin testing and video 
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recorded for 5 min. Time spent in the open arms of the arena (open arm) was quantified using 
Noldus Information Technology EthoVision XT 7 automated tracking software (Leesburg, Va). 
Data is expressed as % time in the open arms 
 
Activated caspase-1 labeling- Following fasting, mice were deeply anesthetized with 
ketamine/xylazine (80mg/kg/ 12mg/kg) then were injected with 100 ng of biotin-YVAD-CMK 
ICV using a microinjection unit attached to a Kopf sterotaxic. 2 Hours following biotin-YVAD-
CMK injection mice were euthanized using CO2 and perfused with ice cold PBS followed by 
4% paraformaldehyde. Brains were sectioned at 1.5 and 3.5 mm from the interaural coronally 
using a Mouse Brain Slicer (Zivic Insttruments, Pittsburgh, PA). Slices were fixed in 4% 
paraformaldehyde for 24 hours then paraffin embedded. 5μm slices from the two sections were 
blocked with hydrogen peroxide (Peroxidazed (PX968)) and labeled with SS HRP Label (4+ 
Strep HRP Label (HP604)), stained with liquid 3.3’-diaminobenzidine (DAB) chromogen (IP 
FLX DAB (IPK5010)), counterstained with hematoxylin (Cat Hematoxylin (CATHE)) and 
mounted and coverslipped with the BioCare IntelliPATH. The entire slide was imaged at 40x 
with a NanoZoomer 2.0-HT (Hamamatsu, Bridgewater, NJ). Area of staining was measured 
using ImageJ (National Institute of Health) and normalized to cell count. Due to variation in 
staining between similar experiments performed on different days results are expressed as % 
control. 
 
Statistics - Data are expressed as mean ± SEM. Analysis was conducted using Sigma Plot 
11.2 (Systat Software, Chicago, IL).  To test for statistical differences, one-way and two-way 
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ANOVAs were used. Data were transformed where necessary to attain normality or equal 




Repeated stress handling impairs recognition memory but not spatial memory or anxiety-
like behavior. To determine the impact of handling stresses on memory, mice were stress 
handled for 3 or 6 hrs. As Fig.1A shows, NOR was impaired 12% (% novel object investigation, 
control vs. stress, 63.61 ± 2.08 vs. 51.32 ± 4.90, p=0.03) following 6 hrs of stresses (Fig. 4.1A). 
In contrast NLR (Fig. 4.1B) and EZM (Fig. 4.1C) were not impacted by 6 hrs of handling 
stresses (% novel location investigation, control vs. stress, 59.91 ± 3.87 vs. 63.86 ± 3.70, 
p=0.473; % time spent in the open arms of the zero maze, control vs. stress, 26.53 ± 2.85 vs. 
25.06 ± 3.87, p=0.763). Importantly, 3 hrs of stress handling did not influence NOR, NLR or 
EZM (data not shown), nor did 6 hrs of normal handling (data not shown). 
 
Repeated stress handling activates caspase-1 in the brain. We have previously shown 
that prolonged global hypoxia activates caspase-1 in the brain (Chiu et al., 2012). To determine if 
milder forms of stress activate brain-based caspase-1 mice, were stress handled for 6 h, as above. 
Fig. 4.2A shows that stress handling increased caspase-1 activity in the amygdala by 86% (% 
control, control vs. stress, 100 ± 10.19 vs. 186.54 ± 28.73, p=0.006). In contrast, stress handling 
does not increase hippocampal caspase-1 activity (% control, control vs. stress, 100 ± 15.20 vs. 
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153.05 ± 26.50, p=0.12). Fig. 4.2B demonstrates that activated caspase-1 is most easily seen in 
neuron bodies in the amygdala.  
 
Mice deficient in caspase-1 or the IL-1R1 lack stress handling-induced memory 
impairment. Similar to Fig.1, caspase-1 KO mice were tested for stress-induced memory 
impairment. Fig. 4.3A demonstrates that capase-1 KO mice were resistant to a stress-induced 
decrease in NOR (% novel object investigation, WT control 66.41 ± 1.77 vs. WT stress 50.34 ± 
2.37 vs. caspase-1 KO 63.56 ± 1.55 vs. caspase-1 KO stress 63.02 ± 2.92; significant stress x 
genotype interaction (p=0.002)). Since caspase-1 is required for maturation of IL-1β, IL-1R1 KO 
mice were next examined for their susceptibility to stress-induced memory impairment (Fig. 
4.3B). Like caspase-1 KO mice, IL-1R1 KO mice were resistant to a stress-induced decrease in 
NOR (% novel object investigation, WT control 65.48 ± 2.45 vs. WT stress 46.07 ± 2.10 vs. IL-
1R1 KO control 67.01 ± 1.87 vs. IL-1R1 KO stress 68.94 ± 2.66; significant stress x genotype 
interaction (p<0.001)). To further explore the importance of IL-1 to stress-induced memory 
impairment, mice administered the IL-1 receptor antagonist, Kineret, were examined (Fig. 4.3C). 
As with caspase-1 KO and IL-1R1 KO mice, Kineret treated mice were protected from a stress-
induced decrease in NOR (% novel object recognition, saline control 67.33 ± 2.32 vs. saline 
stress 51.40 ± 4.10 vs. kineret control 60.133 ± 5.11 vs. kineret stress 63.46 ± 2.07; significant 
stress x kineret interaction (p=0.013)).  
 
Adenosine A2A receptor antagonism prevents stress handling-induced memory 
impairment and the activation of caspase-1 in the amygdala. We have previously shown that 
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mice administered adenosine show an increase in brain IL-1β (Chiu et al., 2014). To determine if 
adenosine signaling was essential to stress handling-induced memory impairment, mice were 
administered the pan-adenosine receptor antagonist caffeine. Fig. 4.4A shows that mice 
administered caffeine were resistant to a stress-induced decrease in NOR (% novel object 
investigation, saline control 69.15 ± 2.76 vs. saline stress 46.89 ± 2.22 vs. caffeine control 66.00 
± 3.89 vs. caffeine stress 62.60 ± 1.70; significant stress x caffeine interaction (p=0.001)). Fig. 
4.4B&C demonstrate that stress-induced caspase-1 activation in the amygdala is also blocked by 
caffeine (% control, saline control 100 ± 7.35 vs. saline stress 158.48 ± 24.11 vs. caffeine control 
72.68 ± 13.48 vs. caffeine stress 96.06, significant effects of stress (p=0.006) and caffeine 
(p=0.003)). To determine which adenosine receptor subtype was responsible for stress-induced 
caspase-1 activation and memory impairment mice were administered either an adenosine A1A 
or A2A receptor inhibitor. Like caffeine, the adenosine A2A receptor antagonist (DMPX) 
prevented stress-handling-induced NOR (% novel object investigation, saline control 70.97 ± 
3.56 vs. saline stress 44.58 ± 3.75 vs. DMPX control 67.92 ± 1.28vs. DMPX stress 63.96 ± 1.88, 
significant stress x DMPX interaction (p=0.001), Fig. 4.4D) and caspase-1 activation in the 
amygdala (% control, DMSO control 100 ± 19.68 vs. DMSO stress 264.91 ± 80.93 vs. DMPX 
control 98.00 ± 29.39 vs. DMPX stress 98.64 ± 30.63; significant effect of DMPX (p=0.044), 
Fig. 4.4E&F). Importantly, the adenosine A1A inhibitor, CPX, had no impact on NOR or 
caspase-1 activity in the amygdala (data not shown). To confirm the role of the adenosine A2A 
receptor in stress induced NOR and caspase-1 activation, A2A KO mice were examined. Like 
caspase-1 and IL-1R1 KO mice, A2A KO mice were resistant to stress handling-induced 
decrease in NOR (% novel object investigation, WT control 64.45 ± 1.47 vs. WT stress 44.50 ± 
2.63 vs. A2A KO control 65.62 ± 2.53 vs. A2A KO stress 62.80 ± 3.19; significant stress x 
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genotype interaction (p=0.002), Fig. 4.4G) and caspase-1 activation (% control, WT control 100 
± 15.07 vs. WT stress 176.6.63 ± 36.34 vs. A2A KO control 92.63 ± 16.26 vs. A2A KO Stress 
135.47 ± 24.19; significant main effect of stress (p=0.016), Fig. 4.4H&I). Importantly, IP 
administered adenosine was sufficient to impair memory and activate caspase-1 in the brain (% 
novel object investigation, saline vs. adenosine, 64.32 ± 2.87 vs. 48.02 ± 1.23 (p<0.001), Fig. 
4.4J; and % control, saline vs. adenosine, 100 ± 19.10 vs. 316.01 ± 62.55 (p=0.003), Fig. 
4.4K&L), respectively. Finally, ICV administration of the caspase-1 inhibitor, YVAD, was able 
to prevent adenosine-dependent impairment of NOR (% novel object investigation, saline saline 
70.22 ± 10.16 vs. saline adenosine 50.90 ± 4.50 vs. YVAD saline 71.60 ± 3.10 vs. YVAD 
adenosine 64.19 ± 4.63; significant main effect of adenosine (p=0.026), Fig. 4.4M). 
 
Catecholamine but not glucocorticoid antagonism blocks stress handling-induced 
memory impairment and caspase-1 activation. Canonically, stress activates the sympathoadrenal 
system (Kvetnansky et al., 1995). To determine if catecholamine signaling was essential to stress 
handling-induced memory impairment and caspase-1 activation, mice were administered the β-
adrenergic receptor antagonist, propranolol. Fig. 4.5A&B show that mice administered 
propranolol were resistant to a stress-induced decrease in NOR and caspase-1 activation in the 
amygdala (% novel object recognition, saline control 62.35 ± 2.65 vs. saline stress 50.93 ± 3.89 
vs. propranolol control 67.95 ± 2.3 vs. propranolol stress 63.77 ± 3.02; significant effect of stress 
treatment (p=0.016) and propranolol treatment (p=0.005) Fig. 4.5A; % control, saline control 
100 ± 25.15 vs. saline stress 232.06 ± 57.77 vs. propranolol control 67.28 ± 39.03 vs. 
propranolol stress 91.19 ± 21.61; significant stress x propranolol interaction (p=0.042), Fig. 
4.5B&C). In contrast, the glucocorticoid receptor antagonist, mifepristone did not impact stress 
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handling induced NOR (% novel object investigation, DMSO control 62.32 ± 1.56 vs. DMSO 
stress 44.16 ± 1.89 vs. mifepristone control 62.38 ± 3.45 vs. mifepristone stress 49.80 ± 2.46; 
significant effect of stress treatment (p<0.001), Fig.5D. 
 
Fasting eliminates stress-induced memory impairment. To determine if low energy levels 
could also reduce the cognitive effects of stress mice were fasted for 24 hrs, with fasting and 
stress exposure ending simultaneously. While stressed animals had 13% reduced NOR 
performance when ad lib fed, fasted animals exhibited no memory impairment following stress 
(% novel object recognition, Fed control 62.93 ± 5.56 vs. fed stress 50.07 ± 2.26 vs. fasted 
control 64.11 ± 5.02 vs. fasted stress 67. 25 ± 3.19, significant fast x stress interaction (p=0.042)) 
(Fig. 4.6A).  
 
Discussion 
In real-world and experimental stress, type, duration, and intensity of the stressor play an 
important role in the phenotypic manifestations observed (Gray et al., 2015). The novel model of 
acute stress deployed here utilizes procedures that rodents involved in basic research experience 
regularly. These types of “handling stressors” were also chosen to lay groundwork for a model of 
human stress in the hospital setting. While white coat hypertension is a well delineated 
physiologic manifestation of anxiety and/or fear in the clinic (Jhalani et al., 2005), much less is 
understood about “routine” interventions and their impact on patient well-being especially with 
regard to cognitive function. “Sundowning”, most often recognized as late afternoon/evening 
confusion in the elderly patient (Gnanasekaran, 2016), is a well characterized syndrome of 
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unknown cause that may be triggered by activities such as shift changes and or interventions that 
occur late in the day (Gnanasekaran, 2016). However, a variety of biological factors are 
proposed in its ethology including: disruptions and/or fluctuations in circadian rhythm, 
glucocorticoid metabolism, sympathomimetic neurotransmission and pro-inflammatory 
cytokines (Gnanasekaran, 2016).       
 
In general, studies examining rodent stress tend to employ chronic discomfort as in the 
unpredictable stress paradigm (Musazzi et al., 2017) or notable acute stress like restraint and foot 
shock (Der-Avakian et al., 2007, Campeau et al., 2010). Just prior to these procedures rodents 
are likely handled so as to get them into the stress device, or to administer a biologic that impacts 
stress or pharmacologically validates the type of stress response observed (ie depression or 
anxiety). Interestingly, such handling stress can produce effects independent of the stressor (Kim 
et al., 2018). As Fig.1 shows, limited handling stresses do not appear to impact NLR, NOR or 
anxiety like behavior because if mice undergo one round of weigh/scruff/needle-stick, they 
perform similarly to control mice. However, if mice undergo two rounds of weigh/scruff/needle-
stick, they fail to perform the NOR task. These findings highlight the importance of duration 
and/or intensity of stressors. For instance, Vargas-Lopez et al. using restraint stress found that 
temporal extension resulted in new adverse behavioral manifestations. (Vargas-Lopez et al., 
2015). 
 
Following stress in both rodents and humans (Howren et al., 2009) depression (Liu et al., 
2015) and anxiety (Wohleb et al., 2014) are linked to IL-1β. IL-1β is also vital to certain aspects 
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of memory formation (Goshen et al., 2009), and is associated with age-related cognitive 
impairment (Cho et al., 2015). How stress impacts IL-1β-associated memory is much less clear. 
Fig.2 shows that amygdala-based caspase-1 activity is nearly doubled in stress-handled mice and 
that its localization is most observable in neurons. Since spatial memory is hippocampal sensitive 
(Bannerman et al., 2014), it is consistent that NOR was impacted by handling stress while NLR 
was not. In support, recent work implicates the amygdala as a critical integrator of signals 
originating from stress centers of the brain (Fast and McGann, 2017). That stress-dependent 
caspase-1 activity was only significant in the amygdala when compared to the hippocampus was 
somewhat surprising, since IL-1β is increased in the hippocampus following certain types of 
stress (Piskunov et al., 2016). However, it is important to note that while caspase-1 is best 
recognized for its maturing function on pro-IL-1β, it is known to cleave a host of proteins some 
even associated with neuronal function and transmission (Denes et al., 2012). Furthermore, non-
canonical mechanisms of IL-1β maturation are recognized and active in the hippocampus 
(Lukens and Kanneganti, 2015).  
 
To confirm the import of caspase-1 to loss of NOR, caspase-1 KO mice were examined 
and found resistant to handling stress as were IL-1R1 KO mice and mice administered IL-1RA 
(Kineret) (Fig. 3). Overall, these finding are consistent with studies showing that adverse 
behaviors can be rectified through disruption of IL-1 signaling. Examples include using IL-1RA, 
caspase-1 KO, MyD88 KO or IL-1R1 KO to mitigate consequences of experimental autoimmune 
encephalomyelitis (Gentile et al., 2016) and/or hypoxia (Chiu et al., 2012, Johnson et al., 2007). 
In contrast, some work indicates that IL-1β antagonism can lead to defective fear-learning (Jones 
et al., 2017). Although this study looked at long term stress and IL-1RA administration 24-48 hrs 
83 
 
following stress, it is not necessarily inconsistent with the results presented here in that acute 
stress may impact immediate learning in an IL-1-dependent manner via memory consolidation 
(Goshen and Yirmiya, 2007). These differences underscore the inverted u-shaped biologic action 
of IL-1 (Goshen and Yirmiya, 2009) and/or stress (Sapolsky, 2015) in learning and memory. 
 
In previous ex vivo work, we demonstrated that adenosine can increase intracellular 
cAMP, activate PKA and trigger K+ efflux leading to caspase-1 activation (Chiu et al., 2014). In 
mice, circulating adenosine acts as a danger signal that can trigger anterograde amnesia after 
acute severe hypoxia (Chiu et al., 2012). Fig. 4 shows that pan-adenosine receptor antagonism 
with caffeine, selective A2A receptor antagonism with DMPX, or A2A receptor KO ameliorates 
handling stress-induced impairment of NOR and caspase-1 activation in the amygdala. These 
findings suggest that the adenosine/caspase-1 pathway is critical to the etiology of acute stress 
regardless of cause (Chiu and Freund, 2014). In support, chronic unpredictable mild stress 
(CUMS) increases A2A receptor density by 250% in mice (Cunha et al., 2006), and A2A 
receptors are associated with depressive-like behaviors in mice following CUMS (Crema et al., 
2013). Interestingly, naked overexpression of A2A receptors in rats causes similar depressive 
symptoms (Coelho et al., 2014). Finally, adenosine alone was capable of inducing memory 
impairment and activating caspase-1. Correlatively, YVAD injected into the brain prevented 
adenosine-induced memory impairment. Thus, handling-stress appears to trigger learning and 
memory dysfunction through a pathway reliant on A2A receptors, aligning with human clinical 
data showing caffeine can significantly improve memory through blockade of adenosine 
signaling (Bruce et al., 2014, Borota et al., 2014). 
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Chronic stress modulates immunity through a variety of steroid-dependent actions 
including lymphocyte differentiation (Maydych et al., 2017). However, the relevance of 
catecholamines to immune-regulation is less clear, especially when the IL-1 arm of the 
neuroimmune system is examined. Several studies demonstrate that glucocorticoids can activate 
the inflammasome and cause hippocampal neuronal loss (Hu et al., 2016), but Fig.5 shows that 
glucocorticoid receptor antagonism does not ameliorate stress-induced memory impairment. In 
contrast, adrenergic receptor antagonism improved NOR and inhibited activation of caspase-1. In 
general acute stress can impact both the ability to encode and retrieve memories (Liu et al., 1999, 
Nelissen et al., 2018), yet much of this work is focused on glucocorticoids and their ability to 
modulate recall (Atsak et al., 2016). Whether the handling-stress paradigm used here impacts 
attention, working memory, short-term memory or consolidation is not clear, but, since NLR and 
elevated zero-maze performance were unaffected, it did not globally disturb any one facet of the 
learning/memory process.  
 
Linkage of the adrenergic system to increased IL-1β expression is described in peripheral 
blood monocytes (Horstmann et al., 2016), and α- and β-adrenergic receptors influence a variety 
of cognitive processes. In the prefrontal cortex, stimulation of the α-1 adrenergic receptor 
impairs working memory in rats (Arnsten et al., 1999), In contrast, β-1 antagonism improves 
working memory in rodents and primates (Ramos et al., 2005). Interestingly, non-specific 
stimulation of adrenergic receptors appears to improve attention, as the attention deficit 
hyperactivity disorder (ADHD) drugs methylphenidate and atomoxetine increase norepinephrine 
levels (Bymaster et al., 2002). These therapeutics, however, appear an inverted-U shape dose 
effectiveness curve when memory performance is examined (Arnsten and Dudley, 2005). 
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The type of allostatic overload response that is activated is determined by energy level. In 
this model, low energy levels activate a type 1 overload response and beneficial adaptations, and 
high energy levels activate the type 2 overload responses and behavioral dysfunction. As 
psychological stress appears to activate the type 2 overload responses via adrenergic signaling 
and adenosine, we wanted to see if lowering systemic energy levels through fasting could reverse 
the activation of the type 2 responses. Indeed, Fig. 3.6A shows that fasting improves memory 
during psychological stress. This suggests that modulating the overload response using fasting as 
an intervention may be successful for stress related neurological diseases. Indeed, ketogenic 
diets, which mimic the physiology of fasting without inducing energy deficits, have been shown 
to be effective at treating a variety of psychiatric disorders in animals and humans (Bostock et 
al., 2017). 
 
Our findings support a potential pathway in which stress-induced fear leads to increased 
interstitial adenosine. Since ATP is an excitatory neurotransmitter (Pankratov et al., 2006) that 
astrocytes can elaborate in response to adrenergic stimulation (Carriba et al., 2012, Espallergues 
et al., 2007) and extracellular metabolism of ATP to adenosine consistently occurs via 
ubiquitously expressed ecto-nucleotidases (Chiu and Freund, 2014), a transient spike in 
adenosine likely triggers A2A receptor-dependent caspase-1 activation and IL-1β-mediated 
memory impairment. In sum, our data suggest a novel pathway by which catecholamines and 
adenosine act synergistically to increase caspase-1 activation which leads to memory 
impairments. Our work is relevant to recent clinical studies in humans showing that targeting IL-
1β through recombinant antibody therapy significantly reduces cardiovascular events (Ridker et 
al., 2017). Since cardiovascular events are often associated with acute stress (Wirtz and van 
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Kanel, 2017), our finding begin to solidify the triad of CNS-associated danger signals, innate 
immune activation and behavioral response. 
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Figure. 2.1. Fasting reduces caspase-1 activity in the brain (A) Mice were given ad lib access to 
food (Fed) or fasted for 24 hours (Fasted). Caspase-1 activity was measured in whole brain and 
the brain regions indicated. Results are expressed as means ± SEM nM/min/µg total protein; 
n=7-10. (*p<0.05). (B) As in (A), mice were given ad lib access to food (Fed) or fasted for 24 
hours (Fasted). Activated caspase-1 was examined in formalin-fixed paraffin embed sections by 
immunohistochemistry. Results are representative, 40X. (C) As in (A), mice were given ad lib 
access to food (Fed) or fasted for 24 hours (Fasted). As in (B), activated caspase-1 was examined 
in formalin-fixed paraffin embed sections by immunohistochemistry. Activated caspase-1 was 
quantified by image analysis. Results are expressed as means ± SEM % area stained/100 cells;  
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Figure 2.1 (continued) 
n=4. (*p<0.05). (D) As in (A), mice were given ad lib access to food (Fed) or fasted for 24 hours 
(Fasted). IL-1β protein levels were measured by ELISA.  Results are expressed as means ± SEM 


























Figure. 2.2. Fasting lessens anxiety-like behaviors and improves memory. (A) Mice were given 
ad lib access to food (Fed) or fasted for 24 hours (Fasted). Total time spent in the open arms of 
the elevated zero maze was measured. Results are expressed as % time in the open arms; n=12. 
(B) As in (A), mice were given ad lib access to food (Fed) or fasted for 24 hours (Fasted). Total 
distance moved while in the elevated zero maze was measured. Results are expressed as distance 
moved in cm; n= 12. (C) As in (A), mice were given ad lib access to food (Fed) or fasted for 24 
hours (Fasted). Mice were then refed for an additional 24 hours (48 hrs). Novel object 
recognition was performed at the time points indicated. Results are expressed as % novel object 
recognition; n=7-8. (D) As in (C), mice were given ad lib access to food (Fed) or fasted for 24  
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Figure 2.2 (continued)  
hours (Fasted). Mice were then refed for an additional 24 hours (48 hrs). Novel location 
recognition was performed at the time points indicated. Results are expressed as % novel 
location recognition; n=7-8. In (A-D), all results are expressed as means ± SEM; values with * 
are significant at p<0.05 using a one-way ANOVA between fed vs. fast, values with
 # 
are 
significant at p<0.05 using one-sample t-test with novel object preference compared with chance 



























Figure. 2.3. The caspase-1 inhibitor, YVAD, reduces caspase-1 activity in the brain and anxiety 
like behavior. (A) Mice were administered ICV YVAD. 24 hours after YVAD administration 
caspase-1 activity was measured in the brain regions indicated. Results are expressed as means ± 
SEM nM/min/µg total protein; n=6-8 (*p<0.05). (B) Mice were treated as in (A). Total time 
spent in the open arms of the elevated zero maze was measured 24 hours after YVAD 
administration. Results are expressed as % time in the open arms of the maze; n=12-13 
(*p<0.05). (C) Mice were treated as in (A). Total distance moved while in the elevated zero 
maze was measured 24 hours after YVAD administration. Results are expressed as distance 

















Figure. 2.4. Caspase-1 and IL1-R1 knockout (KO) mice are resistant to fasting-induced 
improvements in anxiety-like behavior. (A) Wild type (WT) or caspase-1 KO (Casp-1 KO) mice 
were given ad lib access to food (Fed) or fasted for 24 hours (Fasted). Total time spent in the 
open arms of the elevated zero maze was measured. Results are expressed as % time in the open 
arms of the maze; n=7-10. (B) As in (A), WT or Casp-1 KO mice were given ad lib access to 
food (Fed) or fasted for 24 hours (Fasted). Total distance moved while in the elevated zero maze 
was measured. Results are expressed as distance moved in cm; n=7-10. (C) WT or IL-1R1 mice 
(R1) mice were given ad lib access to food (Fed) or fasted for 24 hours (Fasted). Total time spent 
in the open arms of the elevated zero maze was measured. Results are expressed as % time in the  
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Figure 2.4 (continued)  
open arms of the maze; n=8. (D) As in (C), WT or R1 mice were given ad lib access to food 
(Fed) or fasted for 24 hours (Fasted). Total distance moved while in the elevated zero maze was 
measured. Results are expressed as distance moved in cm; n=8. For (A-D) results are expressed 



























Figure 3.1. HFD refeeding induced memory impairment is correlated with kcal intake. (A) Mice 
were fasted for 24 hr then administered chow (Chow), low-fat diet (LFD), or high-fat diet (HFD) 
for 2 hr following the NOR training phase. Results are expressed as mean ± SEM % novel object 
investigation; n=6-9. (B) Novel object recognition performance was correlated with kcal intake 
during refeeding, significant correlation was observed p=0.007; n=23. (C) Mice were treated as 
in (A) and examined on the NOL task. Results are expressed as mean ± SEM % novel location 
investigation; n=8. (D) Novel location investigation was correlated with kcal intake during 
refeeding, significant correlation was observed p=0.022; n=24. Values in (A and C) without a 
















Figure 3.2. HFD refeeding activates caspase-1 in the amygdala. Mice were fasted for 24 hr then 
immediately refed for 2 hr with normal chow (Chow), low-fat diet (LFD), or high-fat diet (HFD). 
(A) Caspase-1 activity was measured in formalin-fixed paraffin embed sections by 
immunohistochemistry in the amygdala. Results are expressed as mean ± SEM % control; n=11-
13. Values without a common superscript are significantly different (p<0.05). (B) Representative 
images (40x) from (A). (C) Caspase-1 activity was positively correlated with kcal intake during 










Figure 3.3. Caspase-1 and IL-1R1 are required for HFD refeeding-induced memory impairment. 
(A) Wild-type (WT) and Caspase-1 KO (Casp-1 KO) mice were fasted for 24 hr then 
administered chow (Chow), low-fat diet (LFD), or high-fat diet (HFD) for 2 hr following the 
NOR training phase. Results are expressed as mean ± SEM % novel object investigation; n=5-6. 
(B) WT and IL-1R1 KO (IL1R1 KO) mice were treated as in (A) and examined on the NOR 
task. Results are expressed as mean ± SEM % novel object investigation; n=8-12. Values in (A 




















Figure 3.4. Administration of n-acetylcysteine (NAC) eliminates memory impairment and 
caspase-1 activation in the amygdala. Wild-type mice were fasted for 24 hr then administered 
chow (Chow), low-fat diet (LFD), or high-fat diet (HFD) for 2 hr following the NOR training 
phase. (A) Prior to refeeding mice were administered n-acetylcysteine (NAC; 50 mg/kg) or 
saline vehicle control (Sal). Results are expressed as mean ± SEM % novel object investigation; 
n=6-9. (B) Mice were treated as in (A) and examined on the NOL task. Results expressed as 
mean ± SEM % novel location investigation; n=5-6. (C) Mice were fasted for 24 hr then 
immediately refed with Chow, LFD, or HFD following administration of NAC or Saline control.  
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Figure 3.4 (continued)  
Amygdala caspase-1 activity was measured in formalin-fixed paraffin embed sections by 
immunohistochemistry. Results are expressed as mean ± SEM % control; n=4-8. (D) 
Representative images (40x) from (C).  For (A-C) values without a common superscript are 

















Figure 3.5. Free-fatty acid receptor 1 (FFAR1) antagonism during HFD refeeding prevents 
memory impairment. Wild-type mice were fasted for 24 hr then administered chow (Chow), low-
fat diet (LFD), or high-fat diet (HFD) for 2 hr following the NOR training phase. (A) Prior to 
refeeding mice were administered the FFAR1 antagonist DC260126 (FFAR antag; 10 mg/kg) or 
4% DMSO vehicle control (DMSO). Results are expressed as mean ± SEM % novel object 
investigation; n=7-8. (B) Mice were treated as in (A) and examined on the NOL task. Results 
expressed as mean ± SEM % novel location investigation; n=8. (C) Mice were fasted for 24 hr 
then immediately refed with Chow, LFD, or HFD. Prior to refeeding mice were administered 
FFAR antag as in (A and B) then amygdala caspase-1 activity was measured in formalin-fixed  
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Figure 3.5 (continued)  
paraffin embed sections by immunohistochemistry. Results are expressed as mean ± SEM % 
control; n=6-8. (D) Representative images (40x) from (C).  For (A-C) values without a common 
















Figure 4.1. Stress impairs recognition memory but has no effect on spatial memory or anxiety-
like behavior. (A) Mice were assigned to either a control condition (control) or exposed to 
stressors for 6hr (stress). NOR was performed 3 hr following stress exposure. Results are 
expressed as mean ± SEM % novel object investigation; n=7 (*p<0.05). (B) Mice were treated as 
in (A) and NLR was performed 3 hr following stress exposure. Results are expressed as mean ± 
SEM % Novel location investigation; n=8. (C) As in (A) and (B) mice were either exposed to  
normal  conditions or stressed for 6 hr. EZM was performed 1 hr following stress exposure. 

















Figure 4.2. Activation of IL-1β by caspase-1 in the amygdala is essential for stress-induced 
memory impairment. (A) Mice were exposed to control conditions (control) or stress stimuli for 
6 hr (stress). Activated caspase-1 was examined by immunohistochemistry using the biotin-
YVAD-cmk probe that selectively binds active caspase-1. Results are expressed as mean ± SEM 
vs. control group; n=10-12 (*p<0.05). (B) is representative images (40x) from the hippocampus 

















Figure 4.3.  Inhibition of IL-1β signaling ameliorates memory impairment following stress 
exposure. (A) C57 and Casp-1 KO mice were exposed to control conditions (control) or stress 
handling (stress) for 6hr. NOR was performed 3 hr following stress exposure. NOR was 
performed 3 hr following stress exposure. Results are expressed as mean ± SEM % novel object 
investigation; n=8. (B) As in (A) C57 and IL1R1 KO (IL1R1) mice were subjected to either 
control conditions or stress handling for 6 hr and NOR was performed 3 hr following stress 
exposure.  Results are expressed as mean ± SEM % novel object recognition; n=7-9. (C) Mice 
were exposed stress or control conditions as in (A & B) immediately following administration of 
the IL1R1 inhibitor Kineret. NOR was performed 3 hr following stress exposure. Results are  
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Figure 4.3 (continued)  
expressed as mean ± SEM % novel object recognition. For both (A-C) values without a common 































































Figure 4.4. Adenosine is a critical danger signal mediating caspase-1 activation and memory 
deficits following stress. Mice were exposed to control conditions (control) or stress stimuli 
(stress) for 6 hr. (A) prior to stress exposure mice were administered the pan-adenosine receptor 
antagonist caffeine. NOR was performed 3 hr following stress exposure. Results are expressed as 
mean ± SEM % novel object investigation; n=7-8. (B) Mice were treated as in (A) and caspase-1 
activity was measured by IHC. Results are expressed as mean ± SEM % control vs. saline treated 
controls; n=8-10. (C) Representative images (40x) from the amygdala from (B). (D)Mice were 
stressed as in (A) and administered the A2A specific antagonist DMPX prior to stress exposure 
or a 2% DMSO vehicle control. NOR was performed 3 hr after stress exposure. Results are 
expressed as mean ± SEM % novel object investigation; n= 7-8. (E) Mice were treated as in (D) 
and caspase-1 activity was measured via IHC. Results are expressed as % control vs. DMSO 
treated control mice; n=7-8. (F) Representative amygdala images (40x) from (E). (G) BALB/c 
control and A2A KO mice were stressed as in (A). NOR was performed 3 hr following stress 
exposure. Results are expressed as mean ± SEM % novel object investigation; n=8. (H) BALB/c 
and A2A KO mice were treated as in (G) and caspase-1 activity was measured via IHC. Results  
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Figure 4.4 (continued)  
are expressed as mean ± SEM % control vs. BALB/c controls; n=10-11. (I) Representative 
amygdala images (40x) from (H). (J) Mice were administered saline or adenosine. NOR was 
performed 30 min following adenosine administration. Results are expressed as mean ± SEM % 
novel object investigation; n= 8 (*p<0.05). (K) Mice were treated as in (A) and caspase-1 
activity was measured by IHC. Results are expressed as % control vs. saline; n= 6-8 (*p<0.05). 
(L) Representative amygdala images (40x) from (J). (M) Mice were treated as in (A) but were 
also ICV injected with biotin-YVAD-cmk immediately following adenosine injection. NOR was 
performed 30 min following YVAD injection. Results are expressed as mean ± SEM % novel 

















Figure 4.5. Catecholamines regulate the inflammatory and behavioral response to stress. (A) 
NOR was performed on mice exposed to control conditions (control) or stress stimuli (stress) for 
6 hr. Prior to stress exposure mice were administered the β-adrenergic receptor antagonist 
propranolol or vehicle control. Results are expressed as means ± SEM % novel object 
investigation; n=8. (B) Mice were treated identically to (A) and active caspase-1 was measured 
via IHC. Results are expressed as mean ± SEM % Control vs. saline treated control mice; n=7-9. 
(C) Representative images (40x) from the amygdala of (B). (D) Mice were treated identically to 
(A), but prior to stress exposure mice were administered the glucocorticoid receptor antagonist 




Figure 4.5 (continued)  














Figure 4.6. Fasting eliminates stress-induced memory impairment. (A) NOR was performed on 
mice exposed to control conditions (control) or stress stimuli (stress) for 6 hr. Prior to stress 
exposure mice were fasted so that a 24 hr fast ended simultaneously with the end of the stress 
protocol. NOR was tested 3 hr after stress exposure. Results are expressed as mean ± SEM % 
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